書籍詳細

生殖器系の発生・解剖・機能

P.15 掲載の参考文献

• 1) Sinclair AM, Berta P, et al:A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990;346:240-244

• 2) McElreavey K, Vilain E, et al:A regulatory cascade hypothesis for mammalian sex determination:SRY represses a negative regulator of male development. Proc Natl Acad Sci U S A 1993;90:3368-3372

• 3) Graves JA:Interactions between SRY and SOX genes in mammalian sex determination. Bioessays 1998;20:264-269

• 4) Haber DA, Buckler AJ, et al:An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms'tumor. Cell 1990;61:1257-1269

• 5) Gessler M, Poustka A, et al:Homozygous deletion in Wilms tumors of a zinc-finger gene identified by chromosome jumping. Nature 1990;343:774-778

• 6) Honda S, Morohashi K, et al:Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 1993;268:7494-7502

• 7) Zanaria E, Muscatelli F, et al:An unusual member of the nuclear hormone-receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:635-641

• 8) Muscatelli F, Storm TM, et al:Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994;372:672-676

• 9) Therman E, Susman B:The similarity of phenotype effects caused by Xp and Xq deletions in the human female:a hypothesis. Hum Genet 1990;85:175-183

• 10) 瀬口春道, 監訳:ムーア人体発生学(原著第6版). 2001, 医歯薬出版, 東京 (Moore KL, Presaud TVN:The Developing Human, 6th ed. 1998, WB Saunders, Philadelphia)

• 11) 藤本征一郎, 林宏:性分化の異常. 臨床婦人科産科 1983;37:621-631

• 12) Konishi I, Fujii S, et al:Development of interstitial cells and ovigerous cords in the human fetal ovary:An ultrastructural study. J Anat 1986;148:121-135

• 13) Konishi I, Fujii S, et al:Development of smooth muscle in the human fetal uterus:an ultrastractural study. J Anat 1984;139:239-252

• 14) 安田峯生, 沢野十蔵, 訳:ラングマン人体発生学(第7版). 1996, 医学書院MYW, 東京 (Sadler TW:Langman's Medical Embryology, 7th ed. 1995, Williams & Wilkins, Baltimore)

P.23 掲載の参考文献

• 1) Shawlot W, Behringer RR:Requirement for Lim1 in head-organizer function. Nature 1995;374:425-430

• 2) Miyamoto N, Yoshida M, et al:Defects of urogenital development in mice lacking Emx2. Development 1997;124:1653-1664

• 3) Kreidberg JA, Sariola H, et al:WT-1 is required for early kidney development. Cell 1993;74:679-691

• 4) Luo X, Ikeda Y, Parker KL:A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994;77:481-490

• 5) Birk OS, Casiano DE, et al:The LIM homeobox gene Lhx9 is essential for mouse gonad formation. Nature 2000;403:909-913

• 6) Slavotinek A, Schwarz C, et al:Two cases with interstitial deletions of chromosome 2 and sex reversal in one. Am J Med Genet 1999;86:75-81

• 7) Katoh-Fukui Y, Tsuchiya R, et al:Male-to-female sex reversal in M33 mutant mice. Nature 1998;393:688-692

• 8) Muroya K, Okuyama T, et al:Sex-determining gene(s) on distal 9p:clinical and molecular studies in six cases. J Clin Endocrinol Metab 2000;85:3094-3100

• 9) McLaren A:Development of primordial germ cells in the mouse. Andrologia 1992;24:243-247

• 10) Van Doren M, Broihier HT, et al:HMG-CoA reductase guides migrating primordial germ cells. Nature 1998;396:466-469

• 11) Sinclair AH, Berta P, et al:A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990;346:240-244

• 12) Bardoni B, Zanaria E, et al:A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 1994;7:497-501

• 13) Swain A, Narvaez V, et al:Dax1 antagonizes Sry action in mammalian sex determination. Nature 1998;391:761-767

• 14) YU RN, Ito M, et al:Role of Ahch in gonadal development and gametogenesis. Nat Genet 1998;20:353-357

• 15) Foster JW, Dominguez-Steglich MA, et al:Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994;372:525-530

• 16) Umehara F, Tate G, et al:A novel mutation of desert hedgehog in a patient with 46, XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet 2000;67:1302-1305

• 17) Colvin JS, Green RP, et al:Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 2001;104:875-889

• 18) Huang B, Wang S, et al:Autosomal XX sex reversal caused by duplication of SOX9. Am J Med Genet 1999;87:349-353

• 19) Bishop CE, Whitworth DJ, et al:A transgenic insertion upstream of sox9 is associated with dominant XX sex reversal in the mouse. Nat Genet 2000;26:490-494

• 20) Dobyns WB, Berry-Kravis E, et al:X-linked lissencephaly with absent corpus callosum and ambiguous genitalia. Am J Med Genet 1999;86:331-337

• 21) Tar A, Solyom J, et al:Testicular development in an SRY-negative 46, XX individual harboring a distal Xp deletion. Hum Genet 1995;96:464-468

• 22) Aleck K, Argueso L, et al:True hermaphroditism with partial duplication of chromosome 22 without SRY. Am J Med Genet 1999;85:2-4

• 23) Ogata T, Matsuo N:Turner syndrome and female sex chromosome aberrations:deduction of the principal factors involved in the development of clinical features. Hum Genet 1995;95:607-629

• 24) Edelmann W, Cohen PE, et al:Mammalian MutS homolog 5 is required for chromosome pairing in meiosis. Nat Genet 1999;21:123-127

• 25) Vainio S, Heikkila M, et al:Female development in mammals is regulated by Wnt-4 signalling. Nature 1999;397:405-409

• 26) Crisponi L, Deiana M, et al:The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001;27:159-166

• 27) Ma K, Inglis JD, et al:A Y chromosome gene family with RNA-binding protein homology:candidates for the azoospermia factor AZF controlling human spermatogenesis. Cell 1993;75:1287-1295

• 28) Reijo R, Lee T-Y, et al:Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding gene. Nat Genet 1995;10:383-393

• 29) Sun C, Skaletsky H, et al:An azoospermic man with a de novo point mutation in the Y-chromosomal gene USP9Y. Nat Genet 1999;23:429-432

• 30) Foresta C, Ferlin A, Moro E:Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet 2000;9:1161-1169

• 31) Dong J, Albertini DF, et al:Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996;383:531-535

• 32) Galloway SM, McNatty KP, et al:Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000;25:279-283

• 33) Murray A:Premature ovarian failure and the FMR1 gene. Semin Reprod Med 2000;18:59-66

• 34) Murray A, Webb J, et al:Microdeletions in FMR2 may be a significant cause of premature ovarian failure. J Med Genet 1999;36:767-770

• 35) Mickle JE, Milewski MI, et al:Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels. Am J Hum Genet 2000;66:1485-1495

• 36) Hardelin JP, Levilliers J, et al:Xp22. 3 deletions in isolated familial Kallman's syndrome. J Clin Endocrinol Metab 1993:76:827-831

• 37) Lindner TH, Njolstad PR, et al:A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum Mol Genet 1999;8:2001-2008

• 38) 原口竜摩, 神川真美, ほか:外性器形成過程の分子的解析:未知領域への挑戦. 実験医学 2000;18:752-758

• 39) Mortlock DP, Innis JW:Mutations of HOXA13 in hand-foot-genital syndrome. Nat Genet 1997;15:179-180

• 40) Tomboc M, Lee PA, et al:Insulin-like 3/relaxin-like factor gene mutations are associated with cryptorchidism. J Clin Endocrinol Metab 2000;85:4013-4018

• 41) Kolon TF, Wiener JS, et al:Analysis of homeobox gene HOXA10 mutations in cryptorchidism. J Urol 1999:161:275-280

P.35 掲載の参考文献

• 1) Ginsburg M, Snow MH, McLaren A:Prilnordial germ cells in the mouse embryo during gastrulation. Developmet 1990;110:521-528

• 2) Eddy EM, Clark JM, Gong D:Origin and migration of primordial germ cells in mammals. Gamete Res 1981;4:333-362

• 3) Lawson KA, Hage WJ:Clonal analysis of the origin of primordial germ cells in the mouse. Germline development, Ciba Foundation Symp. 1994;182:68-91

• 4) Tam PPL, Zhou SX:The allocation of epiblast cells to ectodermal and germ-line lineages is influenced by the position of the cells in the gastrulating mouse embryo. Dev Biol 1996;178:124-132

• 5) Yoshimizu T, Obinata M, Matsui Y:Stage-specific tissue and cell interactions play key roles in mouse germ cell specification. Development 2001;128:481-490

• 6) Lawson KA, Dunn NR, et al:Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev 1999;13:424-436

• 7) Ying Y, Liu XM, et al:Requirement of Bmp8b for the generation of primordial germ cells in the mouse. Mol Endocrinol 2000;14:1053-1063

• 8) Ffrench-Constant C, Hollingsworth A, et al:Response to fibronectin of mouse primordial germ cells before, during and after migration. Development 1991;113:1365-1373

• 9) Garcia-Castro MI, Anderson R, et al:Interactions between germ cells and extracellular matrix glycoproteins during migration and gonad assembly in the mouse embryo. J Cell Biol 1997;138:471-480

• 10) Anderson R, Fassler R, et al:Mouse primordial germ cells lacking beta1 integrins enter the germline but fail to migrate normally to the gonads. Development 1999;126:1655-1664

• 11) Bendel-Stenzel MR, Gomperts M, et al:The role of cadherins during primordial germ cell migration and early gonad formation in the mouse. Mech Dev 2000;91:143-152

• 12) Godin I, Wylie CC:TGF beta 1 inhibits proliferation and has a chemotropic effect on mouse primordial germ cells in culture. Development 1991;113:1451-1457

• 13) Keshet E, Lyman SD, et al:Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J 1991;10:2425-2435

• 14) Williams DE, de Vries P, et al:The Steel factor. Dev Biol 1992;151:368-376

• 15) Matsui Y, Zsebo KM, Hogan BL:Embryonic expression of a haematopoietic growth factor encoded by the S1 locus and the ligand for c-kit. Nature 1990;347:667-669

• 16) Matsui Y, Zsebo K, Hogan BL:Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 1992;70:841-847

• 17) Stewart CL, Kaspar P, et al:Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992;359:76-79

• 18) Yoshida K, Taga T, et al:Targeted disruption of gp 130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A 1996;93:407-411

• 19) Cheng L, Gearing DP, et al:Role of leukemia inhibitory factor and its receptor in mouse primordial germ cell growth. Development 1994;120:3145-3153

• 20) Rosner MH, Vigano MA, et al:A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990;345:686-692

• 21) Tanaka SS, Toyooka Y, et al:The mouse homolog of Drosophila Vasa is required for the development of male germ cells. Genes Dev 2000;14:841-853

• 22) McLaren A, Southee D:Entry of mouse embryonic germ cells into meiosis. Dev Biol 1997;187:107-113

• 23) Rucker EB 3rd, Dierisseau P, et al:Bc1-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol Endocrinol 2000;14:1038-1052

• 24) Print CG, Loveland KL, et al:Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci U S A 1998;95:12424-12431

• 25) Knudson CM, Tung KS, et al:Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995;270:96-99

• 26) Gubbay J, Collignon J, et al:A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 1990;346:245-250

• 27) Koopman P, Munsterberg A, et al:Expression of a candidate sex-determining gene during mouse testis differentiation. Nature 1990;348:450-452

• 28) Call KM, Glaser T, et al:Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms'tumor locus. Cell 1990;60:509-520

• 29) Kreidberg JA, Sariola H, et al:WT-1 is required for early kidney development. Cell 1993;74:679-691

• 30) Wagner T, Wirth J, et al:Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994;79:1111-1120

• 31) Zanaria E, Muscatelli F, et al:An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:635-641

• 32) Muscatelli F, Strom TM, et al:Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994;372:672-676

• 33) Luo X, Ikeda Y, Parker KL:A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994;77:481-490

• 34) Shinoda K, Lei H, et al:Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev Dyn 1995;204:22-29

• 35) Vainio S, Heikkila M, et al:Female development in mammals is regulated by Wnt-4 signalling. Nature 1999;397:405-409

• 36) Behringer RR, Finegold MJ, Cate RL:Mullerian-inhibiting substance function during mammalian sexual development. Cell 1994;79:415-425

• 37) Colvin JS, Green RP, et al:Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 2001;104:875-889

• 38) Hacker A, Capel B, et al:Expression of Sry, the mouse sex determining gene. Development 1995;121:1603-1614

• 39) Capel B, Albrecht KH, et al:Migration of mesonephric cells into the mammalian gonad depends on Sry. Mech Dev 1999;84:127-131

• 40) Pontiggia A, Rimini R, et al:Sex-reversing mutations affect the architecture of SRY-DNA complexes. EMBO J 1994;13:6115-6124

• 41) Pelletier J, Schalling M, et al:Expression of the Wilms'tumor gene WT1 in the murine urogenital system. Genes Dev 1991;5:1345-1356

• 42) Mundlos S, Pelletier J, et al:Nuclear localization of the protein encoded by the Wilms'tumor gene WT1 in embryonic and adult tissues. Development 1993;119:1329-1341

• 43) Hsu SY, Kubo M, et al:Wilms' tumor protein WT1 as an ovarian transcription factor:decreases in expression during follicle development and repression of inhibin-alpha gene promoter. Mol Endocrinol 1995;9:1356-1366

• 44) Englert C, Hou X, et al:WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 1995;14:4662-4675

• 45) Drummond IA, Madden SL, et al:Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 1992;257:674-678

• 46) Ryan G, Steele-Perkins V, et al:Repression of Pax-2 by WT1 during normal kidney development. Development 1995;121:867-875

• 47) Dey BR, Sukhatme VP, et al:Repression of the transforming growth factor-beta 1 gene by the Wilms'tumor suppressor WT1 gene product. Mol Endocrinol 1994;8:595-602

• 48) Rupprecht HD, Drummond IA, et al:The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 1994;269:6198-6206

• 49) Nachtigal MW, Hirokawa Y, et al:Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 1998;93:445-454

• 50) Morais da Silva S, Hacker A, et al:Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat Genet 1996;14:62-68

• 51) Oreal E, Pieau C, ct al:Early expression of AMH in chicken embryonic gonads precedes testicular SOX9 expression. Dev Dyn 1998;212:522-532

• 52) Swain A, Narvaez V, et al:Dax 1 antagonizes Sry action in mammalian sex determination. Nature 1998;391:761-767

• 53) Ito M, YU R, Jameson JL:DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 1997;17:1476-1483

• 54) Tamai KT, Monaco L, et al:Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol Endocrinol 1996;10:1561-1569

• 55) Ikeda Y, Swain A, et al:Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages:potential links in endocrine development. Mol Endocrinol 1996;10:1261-1272

• 56) Honda S, Morohashi K, et al:Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 1993;268:7494-7502

• 57) Lala DS, Syka PM, et al:Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc Natl Acad Sci U S A 1997;94:4895-4900

• 58) Caron KM, Ikeda Y, et al:Characterization of the promoter region of the mouse gene encoding the steroidogenic acute regulatory protein. Mol Endocrinol 1997;11:138-147

• 59) Cammas FM, Pullinger GD, et al:The mouse adrenocorticotropin receptor gene:cloning and characterization of its promoter and evidence for a role for the orphan nuclear receptor steroidogenic factor 1. Mol Endocrinol 1997;11:867-876

• 60) Hu Z, Zhuang L, et al:Steroidogenic factor-1 is an essential transcriptional activator for gonad-specific expression of promoter I of the rat prolactin receptor gene. J Biol Chem 1997;272:14263-14271

• 61) Giuili G, Shen WH, Ingraham HA:The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian Inhibiting Substance, in vivo. Development 1997;124:1799-1807

• 62) Morohashi K, Iida H, et al:Functional difference between Ad4BP and ELP, and their distributions in steroidogenic tissues. Mol Endocrinol 1994;8:643-653

• 63) Hatano O, Takayama K, et al:Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 1994;120:2787-2797

• 64) Behringer RR, Cate RL, et al:Abnormal sexual development in transgenic mice chronically expressing mullerian inhibiting substance. Nature 1990;345:167-170

• 65) Mishina Y, Rey R, et al:Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 1996;10:2577-2587

• 66) Tremblay JJ, Viger RS:Nuclear receptor Dax-1 represses the transcriptional cooperation between GATA-4 and SF-1 in Sertoli cells. Biol Reprod 2001;64:1191-1199

P.45 掲載の参考文献

• 1) Ohno S:Sex Chromosomes and Sex-linked Genes. 1967, Springer-Verlag, Berlin-Heidelberg-New York

• 2) 大野乾:性の分化と性染色体の進化. 21世紀への遺伝学III, 細胞遺伝学(佐々木本道, 編). 1994; pp113-155, 裳華房, 東京

• 3) Graves JAM, Watson JM:Mammalian sex chromosomes:Evolution of organization and function. Chromosoma 1991;101:63-68

• 4) Lahn BT, Page DC:Four evolutionary strata on the human X chromosome. Science 1999;286:964-967

• 5) Murphy WJ, Sun S, et al:Extensive conservation of sex chromosome organization between cat and human revealed by parallel radiation hybrid mapping. Genome Res 1999;9:1223-1230

• 6) Foster JW, Graves JAM:A SRY-related sequence on the marsupial X chromosome:implications for the evolution of the mammalian testis-determining gene. Proc Natl Acad Sci U S A 1994;91:1927-1931

• 7) Brown CJ, Ballabio A, et al:A gene from the region of the human X-inactivation center is expressed exclusively from the inactive X chromosome. Nature 1991;349:38-44

• 8) Lahn BT, Pearson NM, Jegallan K:The human Y chromosome, in the light of evolution. Nat Rev Genet 2001;2:207-216

• 9) Lucchesi JC:Dosage compensation in flies and worms:the ups and downs of X-chromosome regulation. Curr Opin Genet Dev 1999;8:179-184

• 10) Lyon MF:Gene action in the X-chromosome of the mouse (Mus musculus L). Nature 1961;190:372-373

• 11) Rastan S, Robertson EJ:X-chromosome deletions in embryo-derived (EK) cell lines associated with lack of X-chromosome inactivation. J Embryol Exp Morphol 1985;90:379-388

• 12) Brown CJ, Lafreniere RG, et al:Localization of the X inactivation center on the human X chromosome in Xq13. Nature 1991;349:82-84

• 13) Heard E, Clerc P, Avner P:X-chromosome inactivation in mammals. Annu Rev Genet 1997:31:571-610

• 14) Rastan S:Non-random X-chromosome inactivation in mouse X-autosome translocation embryoslocation of the inactivation centre. J Embryol Exp Morphol 1983;78:1-22

• 15) Penny GD, Kay GF, et al:Requirement for Xist in the X chromosome inactivation. Nature 1996;379:131-137

• 16) Marahrens Y, Panning B, et al:Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes Dev 1997;11:156-166
  pubmed

• 17) Lee JT, Jaenisch R:Long range cis effects of ectopic X-inactivation centers on a mouse autosome. Nature 1997;386:275-279

• 18) Heard E, Mongelard F, et al:Xist yeast artificial chromosome transgenes functions X-inactivation centers only in multicopy arrays and not as single copies. Mol Cell Biol 1999;19:3156-3166
  pubmed

• 19) Lee JT:Disruption of imprinted X inactivation by parent-of-origin effects of Tsix. Cell 2000;103:17-27

• 20) Sado T, Wang Z, et al:Regulation of imprinted X-chromosome inactivation in mice by Tsix. Development 2001;128:1275-1286

• 21) Clemson CM, McNeil JA, et al:XIST RNA paints the inactive X chromosome at interphase:evidencefor a novel RNA involved in nuclear/chromosome structure. J Cell Biol 1996;132:259-275

• 22) Avner P, Heard E:X-chromosome inactivation:counting, choice and initiation. Nat Rev Genet 2001;2:59-67

• 23) Johnston PG, Cattanach BM:X controlling elements in the mouse. IV, Evidence of non-random X-inactivation. Genet Res 1981;37:151-160

• 24) Plenge RM, Hendrich BD, et al:A promoter mutation in the XIST gene in two families with skewed X-chromosome inactivation. Nat Genet 1997;17:353-356

• 25) Greer WL, Kwong PC, et al:X-chromosome inactivation in the Wiskott-Aldrich syndrome:a marker for detection of the carrier state and identification of cell lineages expressing the gene defect. Genomics 1989;4:60-67

• 26) Puck JM, Nussbaum RL, Conley ME:Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J Clin Invest 1987:79:1359-1400

• 27) Fearon ER, Winkelstein JA, et al:Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation. N Engl Med 1987;316:427-431

• 28) Gale RE, Wheadon H, et al:Tissue specificity of X-chromosome inactivation patterns. Blood 1994:83:2899-2905

P.53 掲載の参考文献

• 1) Kajii T, Ohama K:Androgenetic origin of hydatidiform mole. Nature 1977;268:633-634

• 2) Surani MAH, Barton SC, Norris ML:Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 1984;308:548-550

• 3) Nakao M, Sasaki H:Genomic imprinting:Significance in development and diseases and the molecular mechanisms. J Biochem 1996;120:467-473

• 4) Cattanach BM, Kirk M:Differential activity of maternally and paternally derived chromosome regions in mice. Nature 1985;315:496-498

• 5) Cattanach BM, Beechey CV:Genomic imprinting in the mouse:possible final analysis. Genomic Imprinting (Reik W, Surani MA, eds). 1997;pp118-145, IRL Press, Oxford

• 6) 佐々木裕之:インプリンティング. 岩波講座現代医学の基礎5, 生殖と発生(森 崇英, 山村研一, 編). 1999;pp183-194, 岩波書店, 東京

• 7) 金児-石野知子, 石野史敏:インプリンティング遺伝子の分離法. Mol Med 1998;35:866-878

• 8) Kato Y, Rideout WM 3rd, et al:Developmental potential of mouse primordial germ cells. Development 1999;126:1823-1832

• 9) Obata Y, Kaneko-Ishino T, et al:Disruption of primary imprinting during oocyte growth leads to the modified expression of imprinted genes during embryogenesis. Development 1998;125:1553-1560

• 10) Ueda T, Abe K, et al:The paternal methylation imprint of the mouse H19 locus is acquired in the gonocyte stage during foetal testis development. Genes Cells 2000;5:649-659

• 11) Ben-Porath I, Cedar H:Imprinting:focusing on the center. Curr Opin Genet Dev 2000;10:550-554

• 12) Young LE, Sinclair KD, Wilmut I:Large offspring syndrome in cattle and sheep. Rev Reprod 1998;3:155-163

• 13) Ohgane J, Wakayama T, et al:DNA methylation variation in cloned mice. Genesis 2001;30:45-50

• 14) Li E, Beard C, Jaenisch R:Role for DNA methylation in genomic imprinting. Nature 1993;366:362-365

• 15) Mayer W, Nivleau A, et al:Demethylation of the zygotic paternal genome. Nature 2000;403:501-502

• 16) Monk M, Boubelik M, Lehnert S:Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 1987;99:371-382

• 17) Reik W, Walter J:Genomic imprinting:Parental influence on the genome. Nature Rev Genet 2001;2:21-32

• 18) 大野乾:メンデルの法則に従わない遺伝子群-胎児発生期に別行動する父由来・母由来の遺伝子. 実験医学 1988;6:475-481

• 19) Moore T, Haig D:Genomic imprinting in mammalian development:a parental tug-of-war. Trends Genet 1991;7:45-49

P.66 掲載の参考文献

• 1) 藤本征一郎, 林 宏:性分化の異常. 臨床産科婦人科 1983;37:621-631

• 2) Hunter RHF:Sex Determination, Differentiation, and Intersexuality in Placental Mammals. 1995, Cambridge University Press, Cambridge

• 3) Sinclair AH:Human sex determination. J Exp Zool 1998;281:501-505

• 4) Bridges CB:Non-disjunction as a proof of the chromosome theory of heredity. Genetics 1916;1:1-52

• 5) Painter TS:Studies in mammalian spermatogenesis. II. The spermatogenesis of man. J Exp Zool 1923;37:291-335

• 6) Tjio JH, Levan A:The chromosome number of men. Hereditas 1956;42:1-6

• 7) Lejeune J, Turpin R, Gautier M:Analyse caryotipique de trois pseudo-hermaphrodites masculins. C R Acad Sci 1959;250:618-620

• 8) Jacobs PA, Strong JA:A case of human intersexuality having a possible XXY sex determining mechanism. Nature 1959;183:302-303

• 9) Barr ML, Shaver EL, Carr DH:An unusual sex chromosome pattern in three mentally deficient subjects. J Ment Defic Res 1959;3:78-87

• 10) Fraccaro M, Kaijser K, Linsten J:A child with 49 chromosomes. Lancet 1960;ii:899-902

• 11) Ford CE, Jones KW, et al:A sex-chromosome anomaly in case of gonadal dysgenesis (Turner's syndrome). Lancet 1959;i:711-713

• 12) Welshons WJ, Russell LB:The Y chromosome as the bearer of male determining factors in the mouse. Proc Natl Acad Sci U S A 1959;45:560-566

• 13) Jost A:Recherches sur la differenciation sexuelle de l'embryon de lapin. III Roles des gonades foetales dans la differenciation sexuelle somatique. Arch Anat Microsc Morphol Exp 1947;36:271-315

• 14) Jost A, Vigier B, et al:Studies on sex differentiation in mammals. Recent Prog Horm Res 1973;29:1-41

• 15) Ford CE:Cytogenetics and sex determination in man and mammals. J Biosoc Sci 1970;2 [Suppl]:7-30

• 16) Ohno S:Major regulatory genes for mammalian sexual development. Cell 1976;7:315-321

• 17) Jacobs PA, Ross A:Structural abnormalities of the Y chromosome in man. Nature 1966;210:352-354

• 18) Vergnaud G, Page DC, et al:A deletion map of the human Y chromosome based on DNA hybridization. Am J Hum Genet 1986;38:109-124

• 19) Page DC, Mosher R, et al:The sex-determining region of the human Y chromosome encodes a finger protein. Cell 1987;51:1091-1104

• 20) Sinclair AH, Berta P, et al:A gene from the human sex-determining region encodes a protein with homology to conserved DNA-binding motif. Nature 1990;346:240-244

• 21) Koopman P, Gubbay J, et al:Male development of chromosomally female mice transgenic for Sry. Nature 1991;351:117-121

• 22) Wachtel SS, Ohno S, et al:Possible role for H-Y antigen in the primary determination of sex. Nature 1975;257:235-236

• 23) Eichwald EJ, Silmser CR:Untitled communication. Transplant Bull 1995;2:148-149

• 24) Goldberg EH, Boyse EA, et al:Serological demonstration of H-Y (male) antigen on mouse sperm. Nature 1971;232:478-480

• 25) Wachtel SS:The genetics of intersexuality:clinical and theoretical perspectives. Obstet Gynecol 1979;54:671-685

• 26) Simpson E:Review lecture. Immunology of H-Y antigen and its role in sex determination. Proc R Soc Lond B 1983:220:31-46

• 27) McLaren A, Simpson E, et al:Male sexual differentiation in mice lacking H-Y antigen. Nature 1984:312:552-555

• 28) Muller U, Zenzes MT, et al:Appearance of hCG-receptor after conversion of newborn ovarian cells into testicular structures by H-Y antigen in vitro. Hum Genet 1978;45:203-207

• 29) Ohno S, Nagai Y, Ciccarese S:Testicular cells lysostripped of H-Y antigen organize ovarian follicle-like aggregates. Cytogenet Cell Genet 1978;20:351-364

• 30) Zenzes MT, Wolf U, Engel W:Organization in vitro of ovarian cells into testicular structures. Hum Genet 1978a;44:333-338

• 31) Zenzes MT, Wolf U, et al:Studies on the function of H-Y antigen:dissociation and reorganization on rat gonadal tissue. Cytogenet Cell Genet 1978a:20:365-372

• 32) Wolf U:Genetic aspects of H-Y antigen. Hum Genet 1981;58:25-28

• 33) Simpson E, McLaren A, et al:Expression of H-Y antigen by female mice carrying Sxr. Transplantation 1984;37:17-21

• 34) McLaren A, Hunt R, Simpson E:Absence of any male-specific antigen recognized by T lymphocytes in X/X Sxr' male mice. Immunology 1988;63:447-449

• 35) Simpson E, Chandler P, et al:Separation of the genetic loci for the H-Y antigen and for testis determination on human Y chromosome. Nature 1987;326:876-878

• 36) Cantrell MA, Bogan JS, et al:Deletion mapping of H-Y antigen to the long arm of the human Y chromosome. Genomics 1992;13:1255-1260

• 37) Burgoyne PS, Levy E, McLaren A:Spermatogenic failure in male mice lacking H-Y antigen. Nature 1986:320:170-172

• 38) Ma K, Sharkey A, et al:Towards the molecular localization of the AZF locus:mapping of microdeletions in azoospermic men within 14 subintervals of interval 6 of the human Y chromosome. Hum Mol Genet 1992;1:29-33

• 39) Vogt P, Chandley AC, et al:Microdeletions in interval 6 of the Y chromosome of males with idiopathic sterility point to disruption of AZF, a human spermatogenesis gene. Hum Genet 1992;89:491-496

• 40) Singh L, Purdom IF, Jones KW:Sex chromosome-associated satellite DNA. Evolution and conservation. Chromosoma 1980;79:137-157

• 41) Epplen JT, McCarrey JR, et al:Base sequence of a cloned snake W chromosome fragment and identification of a male-specific putative mRNA in the mouse. Proc Natl Acad Sci USA 1982;79:3798-3802

• 42) Schafer R, Ali S, Epplen JT:The organization of the evolutionarily conserved GATA/GACA repeats in the mouse genome. Chromosoma 1986;93:502-510

• 43) Jones KW, Singh L:Conserved repeated DNA sequences in vertebrate sex chromosomes. Hum Genet 1981;58:46-53

• 44) Singh L, Purdom IF, Jones KW:Conserved sex-chromosome-associated nucleotide sequences in eukaryotes. Cold Spring Harb Symp Quant Biol 1981;45:805-813

• 45) Singh L, Jones KW:Sex reversal in the mouse (Mus musculus) is caused by a recurrent nonreciprocal crossover involving the X and an aberrant Y chromosome. Cell 1982;28:205-216

• 46) Epplen JT, Cellini A, et al:An attempt to approach the molecular mechanisms of primary sex determination:W-and Y-chromosomal conserved simple repetitive DNA sequences and their differential expression in mRNA. J Exp Zool 1983;228:305-312

• 47) Singh L, Phillips C, Jones KW:The conserved nucleotide sequences of Bkm, which define Sxr in the mouse, are transcribed. Cell 1984;36:111-120

• 48) Kiel-Metzger K, Warren G, et al:Evidence that the human Y chromosome does not contain clustered DNA sequences (Bkm) associated with heterogametic sex determination in other vertebrates. N Engl J Med 1985;313:242-245
  pubmed

• 49) Page DC:Sex reversal:deletion mapping the male-determining function of the human Y chromosome. Cold Spring Harb Symp Quant Biol 1986;51:229-235

• 50) Schnelder-Gadicke A, Beer-Romero P, et al:ZFX has a gene structure similar to ZFY, the putative human sex determinant, and escapes X inactivation. Cell 1989;57:1247-1258

• 51) Sinclair AH, Poster JW, et al:Sequences homologous to ZFY, a candidate human sex-determining gene, are autosomal in marsupials. Nature 1988;336:780-783

• 52) Koopman P, Gubbay J, et al:Zfy gene expression patterns are not compatible with a primary role in mouse sex determination. Nature 1989;342:940-942
  pubmed

• 53) Palmer MS, Sinclair AH, et al:Genetic evidence that ZFY is not the testis-determining factor. Nature 1989;342:937-939
  pubmed

• 54) Page DC, Fisher EMC, et al:Additional deletion in sex-determining region of human Y chromosome resolves paradox of X, t(Y;22) female. Nature 1990;346:279-281

• 55) Ner SS:HMG's everywhere. Curr Biol 1992;2:208-210

• 56) Gubbay J, Collignon J, et al:A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 1990;346:245-250

• 57) Denny P, Swift S, et al:A conserved family of genes related to the testis determining gene, SRY. Nucleic Acids Res 1992;20:2887

• 58) Giese K, Amsterdam A, Grosschedl R:DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1. Genes Dev 1991;5:2567-2578

• 59) Nasrin N, Buggs C, et al:DNA-binding properties of the product of the testis-determining gene and a related product. Nature 1991;354:317-320

• 60) Bianchi ME, Falciola L, et al:The DNA binding site of HMG 1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J 1992;11:1055-1063

• 61) Harley VR, Jackson DI, et al:DNA binding activity of recombinant SRY from normal males and XY females. Science 1992;255:453-456

• 62) Koopman P, Munsterberg A, et al:Expression of a candidate sex-determining gene during mouse testis differentiation. Nature 1990;348:450-452

• 63) Berta P, Hawkins JR, et al:Genetic evidence equating SRY and the testis-determining factor. Nature 1990;348:448-450

• 64) Jager RJ, Anvret M, et al:A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature 1990a;348:452-454

• 65) Jager RJ, Ebensperger C, et al:A ZFY-negative 46, XX true hermaphrodite is positive for the Y pseudoautosomal boundary. Hum Genet 1990b;85:666-668

• 66) Hawkins JR, Taylor A, et al:Mutational analysis of SRY:nonsense and missense mutations in XY sex reversal. Hum Genet 1992a;88:471-474

• 67) Hawkins JR, Taylor A, et al:Evidence for increased prevalence of SRY mutations in XY females with complete rather than partial gonadal dysgenesis. Am J Hum Genet 1992b;51:979-984

• 68) McElreavey K, Vilain E, et al:XY sex reversal associated with a nonsense mutation in SRY. Genomics 1992a;13:838-840

• 69) McElreavey K, Vilain E, et al:XY sex-reversal associated with a deletion 5' to the SRY HMG-box in the testis-determining gene and a related protein. Proc Natl Acad Sci U S A 1992b;89:11016-11020

• 70) Muller J, Schwartz M, Skakkebaek NE:Analysis of the sex-determining region of the Y chromosome (SRY) in sex reversed patients:Point-mutation in SRY causing sex-reversion in a 46, XY female. J Clin Endocrinol Metab 1992;75:331-333

• 71) Su H, Lau Y-FC:Identification of the transcriptional unit, structural organization, and promoter sequence of the human sex-determining region Y (SRY) gene, using a reverse genetic approach. Am J Hum Genet 1993;52:24-38

• 72) Haqq CM, King CY, et al:SRY recognizes conserved DNA sites in sex-specific promoters. Proc Natl Acad Sci U S A 1993;90:1097-1101

• 73) Cohen-Haguenauser O, Picard JY, et al:Mapping of the gene for anti-Mullerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet 1987;44:2-6

• 74) Rossi P, Dolci S, et al:Direct evidence that the mouse sex-determining gene Sry is expressed in the somatic cells of male fetal gonads and in the germ cell line in the adult testis. Mol Reprod Dev 1993;34:369-373

• 75) Ferguson-Smith MA, Cooke A, et al:Genotype-phenotype correlations in XX males and their bearing on current theories of sex determination. Hum Genet 1990a;84:198-202

• 76) Abbas NE, Toublanc JE, et al:A possible common origin of "Y-negative" human XX males and XX true hemaphrodites. Hum Genet 1990;84:356-360

• 77) Numabe H, Nagafuchi S, et al:DNA analyses of XX and XX-hypospadiac males. Hum Genet 1992;90:211-214

• 78) de la Chapelle A:The Y-chromosomal and autosomal testis-determining genes. Development 1987;101 [Suppl]:33-38

• 79) Berkovitz GD, Fechner PY, et al:The role of the sex-determining region of the Y chromosome (SRY) in the etiology of 46, XX true hermaphroditism. Hum Genet 1992;88:411-416

• 80) Ogata T, Hawkins JR, et al:Sex reversal in a child with a 46, X, Yp+karyotype:support for the existence of a gene(s), located in distal Xp, involved in testis formation. J Med Genet 1992;29:226-230

• 81) Capel B:Sex in the 90s:SRY and the switch to the male pathway. Annu Rev Physiol 1998;60:497-523

• 82) McElreavey K, Barbaux S, et al:The genetic basis of murine and human sex determination:a review. Heredity 1995;75 (Pt 6):599-611

• 83) Wagner T, Wirth J, et al:Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994;79:1111-1120

• 84) Muscatelli F, Strom TM, et al:Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994;372:672-676

• 85) Bardoni B, Zanaria E, et al:A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 1994;7:497-501

• 86) Foster JW, Dominguez-Steglich MA, et al:Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994;372:525-530

• 87) Kreidberg JA, Sariola H, et al:Wt-1 is required for early kidney development. Cell 1993;74:679-691

• 88) Luo X, Ikeda Y, Parker KL:A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994;77:481-490

• 89) Morohashi K, Iida H, et al:Functional difference between Ad4BP and ELP, and their distributions in steroidogenic tissues. Mol Endocrinol 1994;8:643-653

• 90) Englert C, Hou X, et al:WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 1995;14:4662-4675

• 91) Drummond IA, Madden SL, et al:Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 1992;257:674-678

• 92) Ryan G, Steele-Perkins V, et al:Repression of Pax-2 by WT1 during normal kidney development. Development 1995;121:867-875

• 93) Dey BR, Sukhatme VP, et al:Repression of the transforming growth factor-beta 1 gene by the Wilms'tumor suppressor WT1 gene product. Mol Endocrinol 1994;8:595-602

• 94) Hsu SY, Kubo M, et al:Wilms'tumor protein WT1 as an ovarian transcription factor:decreases in expression during follicle development and repression of inhibin-alpha gene promoter. Mol Endocrinol 1995:9:1356-1366

• 95) Rupprecht HD, Drummond IA. et al:The Wilms'tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 1994;269:6198-6206

• 96) Honda S, Morohashi K, Omura T:Novel cAMP regulatory elements in the promoter region of bovine P-450 (11 beta) gene. J Biochem 1990:108:1042-1049

• 97) Rice DA, Kirkman MS, et al:Analysis of the promoter region of the gene encoding mouse cholesterol side-chain cleavage enzyme. J Biol Chem 1990;265:11713-11720

• 98) Morohashi K, Omura T:Ad4BP/SF-1, a transcription factor essential for the transcription of steroidogenic cytochrome P450 genes and for the establishment of the reproductive function. FASEB J 1996;10:1569-1577

• 99) Parker KL:The roles of steroidogenic factor 1 in endocrine development and function. Mol Cell Endocrinol 1998:140:59-63

• 100) Sadovsky Y, Crawford PA, et al:Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Poc Natl Acad Sci U S A 1995:92:10939-10943

• 101) Caron KM, Ikeda Y, et al:Characterization of the promoter region of the mouse gene encoding the steroidogenic acute regulatory protein. Mol Endocrinol 1997;11:138-147

• 102) Cammas FM, Pullinger GD, et al:The mouse adrenocorticotropin receptor gene:cloning and characterization of its promoter and evidence for a role for the orphan nuclear receptor steroidogenic factor 1. Mol Endocrinol 1997;11:867-876

• 103) Hu Z, Zhuang L, et al:Steroidogenic factor-1 is an essential transcriptional activator for gonad-specific expression of promoter I of the rat prolactin receptor gene. J Biol Chem 1997;272:14263-14271

• 104) Giuili G, Shen W-H, Ingraham HA:The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian Inhibiting Substance, in vivo. Development 1997;124:1799-1807

• 105) Swain A, Narvaez V, et al:Dax1 antagonizes Sry action in mammalian sex determination. Nature 1998;391:761-767

• 106) Swain A, Zanaria E, et al:Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat Genet 1996;12:404-409

• 107) Tamai KT, Monaco L, et al:Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol Endocrinol 1996:10:1561-1569

• 108) Ikeda Y, Swain A, et al:Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages:potential links in endocrine development. Mol Endocrinol 1996;10:1261-1272

• 109) Nachtigal MW, Hirokawa Y, et al:Wilms'tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 1998;93:445-454

• 110) Morais da Silva S, Hacker A, et al:Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat Genet 1996;14:62-68

• 111) Katoh-Fukui Y, Tsuchiya R, et al:Male-to-female sex reversal in M33 mutant mice. Nature 1998;393:688-692

• 112) Hiraoka Y, Ogawa M, et al:Isolation and expression of a human SRY-related cDNA, hSOX20. Biochim BiopH-Ys Acta 1998;1396:132-137

• 113) Viger RS, Mertineit C, et al:Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Mullerian inhibiting substance promoter. Development 1998;125:2665-2675

• 114) 西森克彦:生殖に関連したTGF-βスーパーファミリー. 蛋白質 核酸 酵素 1998;43:491-501

• 115) Hoshi N, Fujita M, et al:Seminoma in a postmenopausal woman who demonstrated a Y;15 translocation in peripheral blood lymphocytes, and at (Y;15)/45, X Turner mosaic pattern in skin fibroblasts. J Med Genet 1998a;35:852-856

• 116) Hoshi N, Tonoki H, et al:Prenatal identification of mos 45, X/46, X, +mar in a normal male baby by cytogenetic and molecular analysis. Prenat Diagn 1998b;18:1316-1322

• 117) 星 信彦, 半田康, 藤本征一郎:産婦人科領域における性分化異常症の細胞・分子遺伝学的解析. Sex Difference and Similarity/性差医学1998;5:68-75

P.90 掲載の参考文献

• 1) 新井康允:脳の性差-男と女の心を探る. 1999, 共立出版, 東京

• 2) MacLusky NJ, Naftolin F:Sexual differentiation of the central nervous system. Science 1981:211:1294-1303

• 3) Beyer C, Green SI, Hutchson JB:Androgen influence sexual differentiation of embryonic mouse hypothalamic aromatase neurons in vitro. Endocrinology 1994;135:1220-1226

• 4) Pomerantz SM, Goy RW, Roy MM:Expression of male-typical behavior in adult female pseudohermaphroditic rhesus:comparison with normal males and neonatally gonadectomized males and females. Horm Behav 1986;20:489-500

• 5) Goy RW, Deputte BL:The effects of diethylstilbestrol (DES) before birth on the development of masculine behavior in juvenile rhesus monkeys. Horm Behav 1996;30:379-386

• 6) Morishima A, Grumbach MM, et al:Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689-3698

• 7) Carani c, Qin K, et al:Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997;337:91-95

• 8) Rochira V, Balestrieri A, et al:Congenital estrogen deficiency:in search of the estrogen role in human male reproduction. Mol Cell Endocrinol 2001;178:107-115

• 9) Carani C, Rochira V, et al:Role of oestrogen in male sexual behaviour:insights from the natural model of aromatase deficiency. Clin Endocrinol 1999;51:517-524

• 10) Norman RL, Spies HG:Cyclic ovarian function in a male macaque:additional evidence for a lack of sexual differentiation in the physiological mechanisms that regulate the cyclic release of gonadotropins in primates. Endocrinology 1986;118:2608-2610

• 11) Fernandez-Guasti A, Kruijver FPM, et al:Sex differences in the distribution of androgen receptors in the human hypothalamus. J Comp Neurol 2000;425:422-435

• 12) Goudsmit E, Flier E, Swaab DF:Changes in vasopressin neurons and fibers and Alzheimer's disease:reversibility in the rat. Prog Clin Biol Res 1989;317:1193-1208

• 13) Maclusky PL, Becker L, et al:Immunocytochemical detection of androgen receptor in human temporal cortex characterization and application of polyclonal androgen receptor antibodies in frozen and paraffin-embedded tissues. J Steroid Biochem Mol Biol 1995;55:197-209

• 14) Beyenburg S, Watzka M, et al:Androgen receptor mRNA expression in the human hippocampus. Neurosci Lett 2000;294:25-28

• 15) Kruijver FPM, Fernandez-Guasti A, et al:Androgen receptor distribution in the human hypothalamus in relation to sex, gender identity, sexual orientation and endocrine status. Trabajos Instituto Cajal 2000;127:123-124

• 16) Ma ZQ, Spreafico E, et al:Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Proc Natl Acad Sci U S A 1993;90:3740-3744

• 17) Lustig RH:Sex hormone modulation of neural development in vitro. Horm Behav 1994;28:383-395

• 18) Toran-Allerand CD:Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro:implication for sexual differentiation. Brain Res 1976;106:407-412

• 19) Toran-Allerand CD:Developmental interaction of estrogens with neurotrophins and their receptors. Neurobiological Effects of Sex Steroid Hormones (Micevych PE, Hammer Jr RP, eds). 1995;pp391-411, Cambridge Univ Press, Cambridge, New York, Melbourne

• 20) Arai Y:Synaptic correlates of sexual differentiation. Trends Neurosci 1981;4:291-293

• 21) Arai Y, Matsumoto A, Nishizuka M:Synaptogenesis and neuronal plasticity to gonadal steroids:implications for the development of sexual dimorphism in the neuroendocrine brain. Curr Top Neuroendocrinol 1986:7:291-307

• 22) Arai Y, Matsumoto A:Synapse formation of the hypothalamic arcuate nucleus during postnatal development in the female rat and its modification by neonatal estrogen treatment. Psychoneuroendocrinology 1978:3:31-41

• 23) Nishizuka M, Arai Y:Synapse formation in response to estrogen in the medial amygdala developing in the eye. Proc Natl Acad Sci U S A 1982;79:7024-7026

• 24) Matsumoto A, Arai Y:Sexual differentiation of neural circuitry in the neuroendocrine brain. Biomed Rev 1997;7:7-15

• 25) Gorski RA, Gordon JH, et al:Evidence for a morphological sex difference within the medial preoptic area of the rat brain. Brain Res 1978;148:333-348

• 26) Ito S, Murakami S, et al:Perinatal androgen exposure decreases the size of the sexually dimorphic medialperoptic nucleus in the rat. Proc Jpn Acad 1986;62B:408-411

• 27) Murakami S, Arai Y:Neuronal death in the developing sexually dimorphic periventricular nucleus of the preoptic area in the female rat:effect of neonatal androgen treatment. Neurosci Lett 1989;102:185-190

• 28) Nishizuka M, Sumida H, et al:Formation of neurons in the sexually dimorphic anteroperiventricular nucleus of the preoptic area of the rat:Effects of the prenatal treatment with testosterone propionate. J Neuroendocrinol 1993;5:569-573

• 29) Arai Y Murakami S, Nishizuka M:Androgen enhances neuronal degeneration in the developing preoptic area:apoptosis in the anteroventral periventricular nucleus (AVPvN-POA). Horm Behav 1994;28:313-319

• 30) Arai Y, Sekine M, Murakami S:Estrogen and apoptosis in the developing sexually dimorphic preoptic area in female rats. Neurosci Res 1996;25:403-407

• 31) Allen LS, Hines M, et al:Two sexually dimorphic cell groups in the human brain. J Neurosci 1989;9:497-506

• 32) LeVay S:A difference in hypothalamic structure between heterosexual and homosexual men. Science 1991;253:1034-1037

• 33) Swaab DF, Hofman MA:Sexual differentiation of the human hypothalamus in relation to gender and sexual orientation. Trends Neurosci 1995;18:264-270

• 34) Zhou JN, Hofman MA, et al:A sex difference in the human brain and its relation to transsexuality. Nature 1995;378:68-70

• 35) Kruijver FP, Zhou JN, et al:Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab 2000;85:2034-2041

• 36) Imperato-McGinley J, Peterson RE, et al:Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5-alpha-reductase deficiency. N Engl Med 1979;300:1233-1237

• 37) Imperato-McGinley J, Miller M, et al:A cluster of male psuedohermaphrodites with 5-alpha-reductase deficiency in Papua New Guinea. Clin Endocrinol (Oxf) 1991;34:293-298

• 38) Colaointo J:As Nature Made Him. 2000, Harper Collins Publishers, London

• 39) Meyer-Bahlburg HFL, Gruen RS, et al:Gender change from female to male in classical congenital adrenal hyperplasia. Horm Behav 1996;30:319-332

• 40) Zucker KJ, Bradley SJ, et al:Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav 1996;30:300-318

• 41) Hampson E:Sexual differentiation of spatial functions in humans. Sexual Differentiation of the Brain (Matsumoto A, ed). 2000;pp279-300, CRC Press, Boca Raton, Florida

• 42) Shaywitz BA, Shaywitz SE, et al:Sex differences in the functional organization of the brain for language. Nature 1995;373:607-609

• 43) Witelson SF, Glezer II, Kiger DL:Women have greater density of neurons in posterior temporal cortex. J Neurosci 1995;15:3418-3428

• 44) Grimshaw GM, Sitarenios SA, Finegan JK:Mental rotation at 7 years:relations with prenatal testosterone levels and spatial experiences. Brain Cogn 1995;29:85-100

• 45) Resnick SM, Berenbaum SA, et al:Early hormonal influences on cognitive functioning in congenital adrenal hyperplasia. Dev Psychol 1986;54:227-237

• 46) Imperato-McGinely J, Pichardo M, et al:Cognitive abilities in androgen-insensitive subjects:comparison with control males and females from the same kindred. Clin Endocrinol (Oxf) 1991;34:341-347

• 47) Hier DB, Crowley WF:Spatial ability in androgen-deficient men. N Engl J Med 1982;306:1202-1205

• 48) Goy RW, Bercovitch FB, McBrair MC:Behavioral masculinization is independent of genital masculinization in prenatally androgenized female rhesus macaques. Horm Behav 1988a;22:552-571

• 49) Goy RW, Uno H, Sholl SA:Psychological and anatomical consequences of prenatal exposure to androgen in female rhesus. Toxicity of Hormones in Prenatal Life (Mori T, Nagasawa H, eds). 1988b;pp127-142, CRC Press, Boca Raton, Florida

• 50) Berenbaum SA, Hines M:Early androgens are related to childhood sex-typed toy preference. Psychol Sci 1992;3:203-206

• 51) 新井康允:幼児の自由画の男女差とアンドロゲン. 人間総合科学 2001;1:105-115

• 52) Iijima M, Arisaka O, et al:Sex differences in children's free drawings:a study on girls with congenital adrenal hyperplasia. Horm Behav 2001;40:99-104

• 53) Munoz-Cueto JA, Gracia-Segura LM, Ruiz-Marcos A:Regional sex differences in spine density along the apical shaft of visual cortex pyramids during postnatal development. Brain Res 1991;540:41-47

• 54) Nishizuka M, Arai Y:Sexual dimorphism in synaptic organization in the amygdala and its dependence on neonatal hormone environment. Brain Res 1981;212:31-38

• 55) Voigt J, Pakkenberg H:Brain weight of Danish children:a forensic material. Acta Anat 1993;116:290-301

• 56) Ankney CD:Sex differences in relative brain size:The measure of woman, too? Intelligence 1992;16:329-336

• 57) Allen LS, Richey ME, et al:Sex differences in the corpus callosum of the living human being. J Neurosci 1991;11:933-942

• 58) Hines M, Chiu L, et al:Cognition and corpus callosum:verbal fluency, visuospatial ability and language lateralization related to midsagittal surface area of callosal subregions. Behav Neurosci 1992;106:3-14

• 59) Allen LS, Gorski RA:Sexual dimorphism of the anterior commissure and masa intermedia of the human brain. J Comp Neurol 1991;312:97-104

• 60) Allen LS, Hines M, et al:Sexual orientation and the size of the anterior commissure in the human brain. Proc Natl Acad Sci U S A 1992;89:7199-7202

• 61) Godstein JM, Seidman LJ, et al:Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb Cortex 2001;11:490-497

• 62) Reisert I, Pilgrim C:Sexual differentiation of monoaminergic neurons:genetic of epigenetic? Trends Neurosci 1991;14:468-473

• 63) Clept C, Schafer AJ, et al:The human SRY transcript. Hum Mol Genet 1993;2:2007-2012

• 64) Lahr G, Maxon SC, et al:Transcription of the Y chromosome gene, Sry, in the adult mouse brain. Mol Brain Res 1995;33:179-182

• 65) Swain A, Zanaria EC, et al:Mouse Dax 1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat Genet 1996;12:404-409

• 66) Ikeda Y, Takeda Y, et al:Comparative localization of Dax-1 and Ad4BP/SF-1 during development of the hypothalamic-pituitary axis suggests their closely related and distinct function. Dev Dyn 2001;220:33-76

P.107 掲載の参考文献

• 1) Larsen WJ:Development of the urogenital system. Human Embryology. 1993;p235, Churchill Livingstone, New York

• 2) Tuchmann-Duplessis H, Haegel P:Illustrated Human Embryology, Vol II. 1972;pp72-73, Springer-Verlag, New York

• 3) 古山順一;性決定のメカニズム. ターナー症候群(岡田義昭, 監). 1995;pp19-26, メジカルレビュー社, 東京

• 4) Berta P, Hawkins JR, et al:Genetic evidence equating SRY and the testis-determining factor. Nature 1990;348:448-450

• 5) Koopman P, Gubbay J, et al:Male development of chromosomally female mice transgenic for SRY. Nature 1991;351:117-121

• 6) Nakagomi Y, Seki S, et al:PCR detection of distal Yp sequences in an XX true hermaphrodite. Am J Med Genet 1991;41:112-114

• 7) 中堀豊:Y染色体-構造・機能・進化一. 蛋白質 核酸 酵素 1996;41(11月特集号):2306-2314

• 8) Shima H, Kuraoka T, Hashimoto T:Testis-determining factor and gonadal dysgenesis. Int J Urol 1997;4;3-7

• 9) 島 博基:器官形成. 岩波講座 現代医学の基礎5, 生殖と発生(森宗英, 山村研一, 編). 1999;pp136-149, 岩波書店, 東京

• 10) Jost A:Recherches sur la differenciation sexuelle de lapin. III. Rore des gonades foetales dans la differenciation sexuelle somatique. Arch Anat Microsc Morphol Exp 1947;36:271-315

• 11) Bruchovsky N, Wilson JD:The conversion of testosterone to 5α-androstane-17β-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem 1968;243:2012-2021

• 12) Siiteri PK, Wilson JD:Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab 1974;38:113-125

• 13) Imperato-McGinley J, Peterson RE:Male pseudohermaphroditism:the complexities of male phenotypic development. Am J Med 1976;61:251-272

• 14) Walters MR:Steroid hormone receptors and the nucleus. Endocr Rev 1985;6:512-543

• 15) O'Malley B:The steroid receptor superfamily:more excitement predicted in the future. Mol Endocrinol 1990;4:363-369

• 16) Shima H, Tsuji M, et al:Postnatal growth of mouse seminal vesicle is dependent on 5α-dihydrotestosterone. Endocrinology 1990;127:3222-3233

• 17) Tsuji M, Shima H, Cunha GR:In vitro androgen-induced growth and morphogenesis of the Wolffian duct within urogenital ridge. Endocrinology 1991;128:1805-1811

• 18) Wilson JD, Lasnitzki L:Dehydrotestosterone formation in fetal tissues of the rabbit and rat. Endocrinology 1971;89:659-668

• 19) Tsuji M, Shima H, et al:5α-reductase activity in developing urogenital tracts of fetal and neonatal male mice. Endocrinology 1994;134:2198-2205

• 20) Grumbach MM, Conte FA:Disorders of sexual differentiation. Williams Textbook of Endocrinology (Wilson JD, Foster DW, et al, eds), 9th ed. 1998;pp1303-1425, WB Saunders, Philadelphia

• 21) Cunha GR:The role of androgens in the epithelio-mesenchymal interactions involved in prostatic morphogenesis in embryonic mice. Anat Rec 1973;175:87-96

• 22) Cunha GR, Donjacour AA, et al:The endocrinology and developmental biology of the prostate. Endocr Rev 1987;8:338-363

• 23) Tsuji M, Shima H, et al:Effect of mesenchymal glandular inductors on the growth and cytodifferentiation of neonatal mouse seminal vesicle epithelium. J Androl 1994;15:565-574

• 24) Shima H Tsuji M, et al:Development of male urogenital epithelia elicited by soluble mesenchymal factors. J Androl 1995;16:233 241

• 25) 島博基, 生駒文彦, ほか:胎生期における性分化. 性差医学シンポジウム 1994:1:18-34

• 26) Keenan BS, Meyer WJ III, et al:Syndrome of androgen insensitivity in man:absence of 5α-dihydrotestosterone binding protein in skin fibroblasts. J Clin Endocrinol Metab 1974;38:1143-1147

• 27) Griffin JE:Testicular feminization associated with a thermolabile androgen receptor in cultured human fibroblasts. J Clin Invest 1979:64:1624-1631

• 28) Griffin JE, Durrant JL:Qualitative receptor defects in families with androgen resistance:failure of stabilization of the fibroblast cytosol androgen receptor. J Clin Endocrinol Metab 1982;55:465-474

• 29) Chang C, Kokontis J, Liao S:Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 1988;240:324-326

• 30) Lubahn DB, Joseph DR, et al:Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988; 240:327-330

• 31) Quigley CA, de Bekkis A, et al:Androgen receptor defects:Historical. clinical, and molecular perspectives. Endocr Rev 1995;16:271-321

• 32) Klocker H, Kasper F, et al:Point mutation in the DNA binding domain of the androgen receptor in two families with Reifenstein syndrome. Am J Hum Genet 1992;50:1318-1327

• 33) 島博基, 橋本知子, 古山順一:Reifenstein 症候群. 遺伝子病マニュアル(上)(垂井清一郎, 多田啓也, 編). Molecular Medicine 1995; 32:334-335

• 34) Yeh S, Chang C:Cloning and characterization of a specific coactivator, ARA 70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 1996:93:5517-5521

• 35) Hawley DK, Roeder RG:Separation and partial characterization of three functional steps in transcription initiation by human RNA polymerase II. J Biol Chem 1985;260:8163-8172

• 36) 島博基, 生駒文彦:Muller管退縮物質について. 日本泌尿器科学会雑誌 1993;84:1747-1758

• 37) 島博基:特集:性分化に関連する遺伝子の最近の話題-Muller管退縮物質の遺伝子. ホルモンと臨床 1997; 45:67-74

• 38) Tran D, Josso N:Localization of anti-Mullerian hormone in the rough endoplasmic reticulum of the developing bovine Sertoli cell using immunocytochemistry with a monoclonal antibody. Endocrinology 1982;111:1562-1567

• 39) Hayashi M, Shima H, et al:Immunocytochemical localization of Mullerian inhibiting substance in the rough endoplasmic reticulum and Golgi apparatus in Sertoli cells of the neonatal calf testis using amonoclonal antibody. J Histochem Cytochem 1984;32:649-654

• 40) Josso N Picard JY, Tran D:The anti-Mullerian hormone. Recent Prog Horm Res 1977;33:117-167

• 41) Budzik GP, Swann DA, et al:Enhanced purification of Mullerian inhibiting substance by lectin affinity chromatography. Cell 1980:21:909-915

• 42) Donahoe PK, Budzik GP, et al:Mullerian inhibiting substance:an update. Recent Prog Horm Res 1982:38:279-33

• 43) Shima H, Donahoe PK, et al:Production of monoclonal antibodies for affinity purification of bovine Mullerian inhibiting substance activity. Hybridoma 1984;3:201-214

• 44) Cate RL, Mattaliano RJ, et al:Isolation of th bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells. Cell 1986;45:685-698

• 45) Haqq C, Lee MM, et al:Isolation of the rat gene for Mullerian inhibiting substance. Genomics 1992;12:665-669

• 46) Cohen-Haguenauer O, Picard J-Y, et al:Mapping of the gene for anti-Mullerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet 1987:44:2-6

• 47) Teixeira J, Donahoe PK:Molecular biology of MIS and its receptors. J Androl 1996;17:336-341

• 48) MacLaughlin DT, Hudson PI, et al:Mullerian duct regression and antiproliferative bioactivities of Mullerian Inhibiting Substance reside in its carboxy-terminal domain. Endocrinology 1992a;131:291-296

• 49) Gustafson ML, Donahoe PK:Mullerian-Inhibiting Substance:Critical roles in sexual differentiation. Molecular Genetics of Sex Determination (Wachtel SS, ed). 1994;pp457495, Academic Press, San Diego

• 50) He WW, Gustafson ML, et al:Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factors-β type II receptor family. Dev Dyn 1993;196:133-142

• 51) Baarends WM, van Helmond MJL, et al:Q novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct. Development 1994;120:189-197

• 52) Teixeira J, He WW, et al:Development expression of a candidate Mullerian inhibiting substance type II receptor. Endocrinology 1996;137:160-165

• 53) Kuroda T, Lee MM, et al:Mullerian inhibiting substance ontogeny and its modulation by follicle-stimulating hormone in the rat testes. Endocrinology 1990;127:1825-1832

• 54) Ikawa H, Hutson JM, et al:Steroid enhancement of Mullerian duct regression. J Pediatr Surg 1982;17:453 458

• 55) Shima H, Kawanaka H, et al:A case of 17α-hydroxylase deficiency with chromosomal karyotype of 46, XY, and high aldosterone concentration. Int Urol Nephrol 1991;23:611-618

• 56) Hutson J, Ikawa H, Donahoe PK:The ontogeny of Mullerian inhibiting substance in the gonads of the chicken. J Pediatr Surg 1981:16:822-827

• 57) Haqq CM, King C-Y, et al:Molecular basis of mammalian sexual determination:activation of Mullerian inhibiting substance gene expression by SRY. Science 1994;266:1494-1500

• 58) Giulli G, Shen W-H, Ingraham HA:The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian inhibiting substance, in vivo. Development 1997:124:1799-1807

• 59) Hutson JM, Fallat ME, et al:Phosphorylation events during Mullerian duct regression. Science 1984;223:586 589

• 60) Tsuji M, Shima H, et al:Effect of human recombinant Mullerian inhibiting substance on isolated epithelial and mesenchyme cells during Mullerian duct regression in the rat Endocrinology 1992;131:1481-1488

• 61) Ggarroa FG, Coughlin JP, et al:Recombinant human Mullerian inhibiting substance inhibits epidermal growth factor receptor tyrosine kinase. Growth Factors 1989;1:179-191

• 62) Coughlin JP, Donahoe PK, et al:Mullerian inhibiting substance blocks autophosphorylation of the EGF receptor by inhibiting tyrosine kinase. Mol Cell Endocrinol 1987;49:75-86

• 63) Catlin E, Utivlug N, et al:Mullerian inhibiting substance blocks epidermal growth factor receptor phosphorylation in fetal rat lung membranes. Metabolism 1991:40:1178-1184

• 64) Donahoe PK, Cate RL, et al:Mullerian inhibiting substance:Gene structure and mechanism of action of a fetal regressor. Recent Prog Horm Res 1987;43:431-467

• 65) Takahashi M, Koide SS, Donahoe PK:Mullerian inhibiting substance as oocyte meiosis inhibitor. Mol Cell Endocrinol 1986;47:225-234

• 66) Zhou B, Hutson JM:Quantitative analysis of germ cell maturation in immature testicular feminization (tfm) mice with complete androgen resistence in vivo and in vitro indicates good development of spermatogonia. The Vth International Congress of Andrology, May 5, 1993, Tokyo

• 67) Hutson J, Donahoe PK:The hormonal control of testicular descent. Endocr Rev 1986;7:270-283

• 68) Josso N, Legeal L, et al:An enzyme linked immunoassay for anti-Mullerian hormone:A new tool for the evaluation of testicular function in infants and children. J Clin Endocrinol Metab 1990;70:23-27

• 69) Hudson PL, Dougas I, et al:An immunoassay to detect human Mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 1990;70:16-22

• 70) Gustafson M, Lee MM, et al:Mullerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities. J Pediatr Surg 1993;28:439-444

• 71) 島博基, 生駒文彦:性分化異常. 小児泌尿器科書(生駒文彦, 監, 川村 猛, 小柳知彦, 編). 1998;pp317-353, 金原出版, 東京

P.117 掲載の参考文献

• 1) Jost A:Problems of fetal endocrinology. Recent Prog Horm Res 1953;8:397-413

• 2) Shimazaki J, Kurihara H, et al:Metabolism of testosterone in prostate. Separation of prostatic 17β-ol-dehydrogenase and 5α-reductase. Gumma J Med Sci 1965;14:326-333

• 3) Griffin JE:Androgen resistance-The clinical and molecular spectrum. N Engl J Med 1992;326:611-618

• 4) Hiort O, Holterhus PM:The molecular basis of male sexual differentiation. Eur J Endocrinol 2000;142:101-110

• 5) Mahendroo MS, Cala KM, et al:Fetal death in mice lacking 5 alpha-reductase type 1 caused by estrogen excess. Mol Endocrinol 1997;11:917-927

• 6) 島博基, 中江和美:5α-還元酵素欠損症. 新図説泌尿器科学講座4, 内分泌疾患, 性機能障害, 性分化異常各論. 1999;pp101-103, メジカルビュー社, 東京

• 7) Wilson JD:Syndrome of androgen resistance. Biol Reprod 1992;46:168-173

• 8) Andersson S, Berman DM, et al:Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 1991;354:159-161

• 9) Silver RI, Russel DW:5α-reductase type 2 mutations are present in some boys with isolated hypospadias. J Urol 1999;162:1142-1145

• 10) Gottlieb B, Lehvaslaiho H, et al:The androgen receptor gene mutations database. Nucleic Acids Res 1998;26:234-238

• 11) Gottlieb B, Beitel LK, et al:Update of the androgen receptor gene mutations database. Hum Mutat 1999;14:103-114

• 12) Gottlieb B, Pinsky L, et al:Androgen insensitivity. Am J Med Genet 1999;89:210-217

• 13) Pelletier J, Bruening W, et al:Germline mutations in the Wilms'tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991;67:437-447

• 14) Schwartz CE, Haber DA, et al:Familial predisposition to Wilms tumor does not segrate with WT1 gene. Genomics 1991;10:927-930
  pubmed

• 15) Pelletier J, Bruening W, et al:WT1 mutations contribute to abnormal genital system development and hereditary Wilms'tumor. Nature 1991;353:431-434

• 16) Simamura R, Fraizer GC, et al:The Wilms'tumor gene WT1 can regulate genes involved in sex determination and differentiation:SRY, Mullerian-inhibiting substance and the androgen receptor. Clin Cancer Res 1997;3:2571-2581

• 17) Mortluck DP, Innis JW:Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet 1997;15:179-180

• 18) Goodman FR, Bacchelli C, et al:Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet 2000;67:197-202

• 19) Kondo T, Zakany J, et al:Of fingers, toes and penises. Nature 1997;390:29
  pubmed

• 20) Haraguchi R, Suzuki K, et al:Molecular analysis of external genitalia formation:the role of fibroblast growth factor (Fgf) genes during genital tubercle formation. Development 2000;127:2471-2479

• 21) Yamaguchi TP, Bradley A, et al:A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 1999;126:1211-1223

• 22) van Bokhoven H, Celli J, et al:Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome. Nat Genet 2000;25:423-426

性分化異常の臨床

P.130 掲載の参考文献

• 1) Su H, Lau YF:Identification of the transcriptional unit, structural organization, and promoter sequence of the human sex-determining region Y (SRY) gene, using a reverse genetic approach. Am J Hum Genet 1993;52:24-38

• 2) Rossi P, Dolci S, et al:Direct evidence that the mouse sex-determining gene Sry is expressed in the somatic cells of malefetal gonads and in the germ cell line in the adult testis. Mol Reprod Dev 1993;34:369-373

• 3) Muscatelli F, Strom TM, et al:Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994;372:672-676

• 4) Bardoni B, Zanaria E, et al:A dosage sensitive locus at chromosome Xp21 is involved in male to re-male sex reversal. Nat Genet 1994;7:497-501

• 5) Wagner T, Wirth J, et al:Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994;79:1111-1120

• 6) Foster JW, Dominguez-Steglich MA, et al:Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994;372:525-530

P.140 掲載の参考文献

• 1) NCBIヒトゲノムホームページ:http://www. ncbi. nlm. nih. gov/genome/guide/human/

• 2) Tiepolo L, Zuffardi O:Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum Genet 1976;34:119-124

• 3) Vergnaud G, Page DC, et al:A deletion map of the human Y chromosome based on DNA hybridization. Am J Hum Genet 1986;38:109-124

• 4) Ma K, Inglis JD, et al:A Y chromosome gene family with RNA-binding protein homology:candidates for the azoospermia factor AZF controlling human spermatogenesis. Cell 1993;75:1287-1295

• 5) Reijo R, Lee TY, et al:Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet 1995;10:383-393

• 6) Brown CJ, Ballabio A, et al:A gene from the region the human X inactivation center is expressed exclusively from the inactive X chromosome. Nature 1991;349:38-44

• 7) 高木信夫:X染色体の不活化と不活化を免れる遺伝子. 分子医科学シリーズ5. 人生命の始まり, ヒト初期発生の分子生物学. 1996;pp37-68, メジカルビュー社, 東京

• 8) Ogata T, Hawkins JR, et al:Sex reversal in a child with a 46, X, Yp+karyotype:support for the existence of a gene (s), located in distal Xp, involved in testis formation. J Med Genet 1992;29:226-230.

• 9) Zanaria E, Muscatelli F, et al:An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:672-676

• 10) Warburton D:De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis:clinical significance and distribution of breakpoints. Am J Hum Genet 1991;49:995-1013

• 11) Hoshi N, Fujita M, et al:Seminoma in a postmenopausal woman who demonstrated a Y;15 translocation in peripheral blood lymphocytes, and a t(Y;15)/45, X Turner mosaic pattern in skin fibroblasts. J Med Genet 1998a;35:852-856

• 12) Hoshi N, Tonoki H, et al:Prenatal identification of mos 45, X/46, X, +mar in a normal male baby by cytogenetic and molecular analysis. Prenat Diagn 1998b;18:1316-1322

• 13) 星信彦, 半田康, ほか:産婦人科領域における性分化異常症の細胞・分子遺伝学的解析. 性差医学 1998c;5:68-75

• 14) Hsu LY F, Perlis T:United States survey on chromosome mosaicism and pseudomosaicism in prenatal diagnosis. Prenat Diagn 1984;4:97-130

P.150 掲載の参考文献

• 1) Turner HH:A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938;23:566-576

• 2) Ullrich O:Uber typische Kombinationsbilder mutipler Abartungen. Zeitschrift fur Kinderheilk 1930:49:271-276

• 3) Ford CE, Jones KW, et al:A sex chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome). Lancet 1959:i:711

• 4) Price WH, Clayton JF, et al:Mortality ratios. life expectancy, and causes of death in patients with Turner's syndrome. J Epidemiol Community Health 1986;40:97-102

• 5) 田中敏章, 口比逸郎, 鎮目和夫:Turner症候群における成長ホルモン(GH)分泌能とGH治療効果の検討-下垂体性小入症との比較. 日本内分泌学会雑誌 1991;67:597-610

• 6) Chandly AC:The origin of chromosomal aberrations in man and their potential for survival and reproduction in the adult human population. Ann Genet 1981;24:5-10

• 7) 黒木良和:新生児集団(5, 026例)の細胞遺伝学的検討. 米子医学雑誌 1983;134:1-7

• 8) Maeda T, Ohno M, et al:A cytogenetic survey of 14, 836 consecutive liveborns. Jpn J Hum Genet 1991;36:117-129

• 9) Suwa S:Standards for growth and growth velocity in Turner's syndrome. Acta Paediatr Jpn 1992;34:206-221
  pubmed

• 10) Ranke MB, Grauer ML:Adult height in Turner syndrome:results of a multinational survey. Horm Res 1993;42:90-94

• 11) Rao E, Weiss B, et al:Pseudoautosomal deletion encompassing a novel homeobox gene:cause of growth failure in idiopathic short stature. Nat Genet 1997;16:5463

• 12) 伊藤純子, 田中敏章, ほか:Turner症候群の臨床症状. 小児内科 1992;24:841-846

• 13) Hibi I, Tanae A:Final height in Turner syndrome with and without gonadal function. Turner Syndrome (Rosenfeld RG, Grumbach MM, eds). 1990;pp 163-174, Marcel Dekker, New York

• 14) Hausler G, Schemper M, et al:Spontaneous growth in Turner syndrome:Evidence for a minor pubertal growth spurt. Turner's Syndrome and Growth-promoting Therapies (Ranke MB, Rosenfeld R, eds). 1991;pp67-73, Excerpta Medica, Amsterdam

• 15) Hibi I, Tanae A, et al:Spontaneous puberty in Turner syndrome:Its incidence, influence on final height and endocrinological features. Turner's Syndrome and Growth-promoting Therapies (Ranke MB, Rosenfeld R, eds). 1991;pp75-81, Excerpta Medica, Amsterdam

• 16) Rosenfield RL:Spontaneous puberty and fertility in Turner syndrome. Turner Syndrome (Rosenfeld RG, Grumbach MM, eds). 1990;pp131-144, Marcel Dekker, New York

• 17) Jones KL:Smith's Recognizable Patterns of Human Malfomiation. 1988;p74, WB Saunders, Philadelphia

• 18) Lippe BM:Primary ovarian failure. Clinical Pediatric Endocrinology (Kaplan SA, ed), 1990;p325, WB Saunders, Philadelphia

• 19) Lippe BM:Physical and anatomical abnormalities in Turner syndrome. Turner Syndrome (Rosenfeld RG, Grumbach MM, eds). 1990;pp183-196, Marcel Dekker, New York

• 20) Clark EB:Neck web and congenital heart defects:A pathogenic association in 45X-O Turner syndrome? Teratology 1984;29:355-361

• 21) Forbes AP, Engel E:The high incidence of diabetes mellitus in 41 patients with gonadal dysgenesis, and their close relatives. Metabolism 1963;12:428-439

• 22) 田中敏章:Turner症候群の合併症. 糖尿病・耐糖能. Turner症候群(岡田義昭, 編). 1995;pp122-128, メディカルレビュー社, 大阪

• 23) Naeraa RW, Gravholt CH, et al:Mortality in Turner syndrome. Turner Syndrome in a Life-Span Perspective (Albertsson-Wikland K, Ranke MB, eds). 1995;p325, Elsevier Science, Amsterdam

• 24) Tanaka T, Takano K, et al:Final height in Turner syndrome after growth hormone treatment;Japanese study. Optimizing Health Care for Turner Patients in the 21st Century (Saenger P, Pasquino AM, eds). 2000;p223, Elsevier Science BV, Amsterdam

• 25) Chernausek S, Attie KM, et al:Growth hormone therapy of Turner syndrome:The impact of age of estrogen replacement on final height. J Clin Endocrinol Metab 2000;85:2439-2445

P.155 掲載の参考文献

• 1) Kobylinsky O:Uber eine flughautahnliche Ausbreitung am Halse. Arch Anthropol 1883;14:343-348

• 2) Noonan JA:Hypertelorism with Turner phenotype. A new syndrome with associated congenital heartdisease. Am J Dis Child 1968;116:373-380

• 3) Cullimore AJ, Smedstad KG, Brennan BG:Pregnancy in women with Noonan syndrome:report oft wo cases. Obstet Gynecol 1999:93:813-816

• 4) Nora JJ, Sinha AK:Dircct familial transmission of the Turner phenotype. Am J Dis Child 1968;116:343-350

• 5) Abdel-Salem E, Temtamy SA:Familial Turner phenotype. J Pediatr 1969;74:67-72

• 6) Baird PA, De Jong BP:Noonan's syndrome (XX and XY Turner phenotype) in three generations of a family. J Pediatr 1972;80:110-114

• 7) Bolton MR, Pugh DM, et al:The Noonan syndrome:a family study. Ann Intern Med 1974;80:626-629

• 8) Qazi QH, Arnon RG, et al:Familial occurrence of Noonan syndrome. Am J Dis child 1974;127:696-698

• 9) McKusick VA:Mendelian inheritance in man. A Catalog of Human Genes and Genetic Disorders, Vol 2, 12th ed. 1998;pp1278-1280. The Johns Hopkins University Press. Baltimore and London

• 10) Jamieson CR, van der Burgt I, et al:Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet 1994;8:357-360

• 11) Brady AE Jamieson CR, et al:Further delineation of the critical region for Noonan syndrome on the long arm of chromosome 12. Eur J Hum Genet 1997;5:336-337

• 12) Legius E, Schollen E, et al:Fine mapping of Noonan/cardio-facio cutaneous syndrome in a large family. Eur J Hum Genet 1998;6:32-37

• 13) Allanson JE:Noonan syndrome. J Med Genet 1987;24:913

• 14) Witt DR, McGillivray BC, et al:Bleeding diathesis in Noonan syndrome:a common association. Am J Med Genet 1988;31:305 317

• 15) Sharland M, Patton MA, et al:Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome. Lancet 1992;339:1921

• 16) Evans DGR, Lonsdale RN, Patton MA:Cutaneous lymphangioma and amegakaryocytic thrombocytopenia in Noonan syndrome. Clin Genet 1991;39:228-232

• 17) Kitchens CS, Alexander JA:Partial deficiency of coagulation factor XI as a newly recognized feature of Noonan syndrome. J Pediatr 1983;102:224-227

• 18) de Haan M, van de Kamp JJP, et al:Noonan syndrome:partial factor XI deficiency. Am J Med Genet 1988;29:277-282

• 19) Sharland M, Patton MA, et al:Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome. Lancet 1992;339:19-21

• 20) Shah N, Rodriguez M, et al:Feeding difficulties and foregut dysmotility in Noonan's syndrome. Arch Dis Child 1999;81:2831

• 21) Donnenfeld AE, Nazir MA, et al:Prenatal sonographic documentation of cystic hygroma regression in Noonan syndrome. Am J Med Genet 1991;39:461-465

• 22) Ranke MB, Heidemann P, et al:Noonan syndrome:growth and clinical manifestations in 144 cases. Eur J Pediatr 1988;148:220-227

• 23) Koretzky ED, Moller JH, et al:Congenital pulmonary stenosis resulting from dysplasia of valve. Circulation 1969;40:43-53

• 24) Allanson JE, Upadhyaya M, et al:Watson syndrome:is it a subtype of type 1 neurofibromatosis? J Med Genet 1991;28:752-756

• 25) Upadhyaya M, Shen M, et:Analysis of mutations at the neurofibromatosis 1 (NF1) locus. Hum Mol Genet 1992;1:735-740

• 26) Gorlin RJ, Anderson RC, Blaw ME:Multiple lentigines syndrome:complex comprising multiple lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonary stenosis, abnormalities of genitalia, retardation of growth, sensorineural deafness, and autosomal dominant hereditary pattern. Am J Dis Child 1969;117:652-662

• 27) Witt DR, Hoyme E, et al:Lymphedema in Noonan syndrome:clues to pathogenesis and prenatal diagnosis and review of the literature. Am J Med Genet 1987;27:841-856

• 28) Butler MG, Kumar R, et al:Metacarpophalangeal pattern profile analysis in Noonan syndrome. Am J Med Genet 2000;92:128-131

• 29) Shah N, Rodriguez M, et al:Feeding difficulties and foregut dysmotility in Noonan's syndrome. Arch Dis Child 1999;81:28-31

• 30) Allanson JE, Hall JG, et al:Noonan syndrome:the changing phenotype. Am J Med Genet 1985;21:507-514

• 31) Elsawi MM, Pryor JR et al:Genital tract function in men with Noonan syndrome. J Med Genet 1994;31:468-470

P.162 掲載の参考文献

• 1) Swyer GIM, Phil D:Male pseudohermaphroditism:a hitherto undescribed form, Br Med J 1955;2:709-712

• 2) 堤治, 難波聡:性分化. 新女性医学大系18巻, 思春期医学. 2000;pp3-13, 中山書店, 東京

• 3) Sinclair AH, Berta P, et al:A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990;346:240-244

• 4) Page DC, Fisher EMC, et al:Additional deletion in sex-determining region of human Y chromosome resolves paradox of X, t(Y;22) female. Nature 1990;346:279-281

• 5) Tsutsumi O, Iida T, et al:Analysis of the testis-determining gene SRY in patients with XY gonadal dysgenesis. Horm Res 1996;46:6-10

• 6) Koopman P, Gubbay J, et al:Male development of chromosomally female mice transgenic for Sry. Nature 1991;351:117-121

• 7) Tsutsumi O, Iida T, et al:Intact sex determining region Y (SRY) in a patient with XY pure gonadal dysgenesis and a twin brother. Endocr J 1994;41:281-285

• 8) Tsutsumi O, Iida T, et al:Y chromosome analysis and laparoscopic surgery in XY pure gonadal dysgenesis:A case report and a review of literature. Asia Oceania J Obstet Gynaecol 1993;19:95-99

• 9) Takai Y, Tsutsumi O, et al:A case of XY pure gonadal dysgenesis with 46, XYp-/47, XXYp-karyo-type whose gonadoblastoma was removed laparoscopically. Gynecol Obstet Invest 2000;50:166-169

• 10) Iida T, Nakahori Y, et al:A novel nonsense mutation in the HMG box of the SRY gene in a patient with XY sex reversal. Hum Mol Genet 1994;3:1437-1438

• 11) Disteche CM, Casanova M, et al:Small deletions of the short arm of the Y chromosome in 46, XY female. Proc Natl Acad Sci U S A 1986;83:7841-7844

• 12) Affara NA, Chalmers IJ, Ferguson-Smith MA:Analysis of the SRY gene in 22 sex-reversed XY female identified four new point mutations in the conserved DNA binding domain. Hum Mol Genet 1993;2:785-789

• 13) Behzadian MA, Tho SPT, McDonough PG:The presence of the testicular determining sequence, SRY, in 46, XY females with gonadal dysgenesis (Swyer syndrome). Am J Obstet Gynecol 1991;165:1887-1890

• 14) Troche V, Hernandez E:Neoplasia arising in dysgenetic gonads. Obstet Gynecol Surv 1986;41:74-79

• 15) Tsutsumi O, Iida T, Taketani Y:Laparoscopic surgery and DNA analysis in patients with XY pure gonadal dysgenesis. J Obstet Gynaecol 1995:21:67-74

• 16) Frydman R, Parneix I, et al:Pregnancy in a 46, XY patient. Fertil Steril 1988;50:813-814

P.170 掲載の参考文献

• 1) Harnden DG, Stewart JS:The chromosomes in a case of pure gonadal dysgenesis. Br Med J 1959;2:1285-1287

• 2) Swyer GIM:Malepseudohermaphroditism:A hitherto undescribed form. Br Med J 1955;2:709-712

• 3) Grumbach MM, Conte FA:Disorders of sexual differentiation. Williams Textbook of Endocrinology (Wilson JD, Foster DW, et al, eds), 9th ed. 1998;pp 1331-1425, WB Saunders, Philadelphia

• 4) Aittomaki K:The genetics of XX gonadal dysgenesis. Am J Hum Genet 1994;54:844-851

• 5) Griffin JE, Wilson JD:Disorders of sexual differentiation. Campbell's Urology (Walsh PC, Retik AB, et al, eds), 6th ed. 1992;pp1509-1542, WB Saunders, Philadelphia

• 6) de la Chapelle A, Hortling H, et al:XX sex chromosomes in a human male;first case. Acta Med Scand 1964;412 (Suppl) 25-38

• 7) 藪元秀典, 島 博基, 生駒文彦:XX-男性. 図説泌尿器科学講座(4) (吉田修, 三宅弘治, 編). 1991;pp74-75, メジカルビュー社, 東京

• 8) 木川源則, 大島博幸:Klinefelter症候群とXX male. 性の分化と異常. 1983;pp50-58, 医歯薬出版, 東京

• 9) Shima H, Kuraoka T, Hashimoto T:Testis-determining factor and gonadal dysgenesis. Int J Urol 1997;4;3-7

• 10) 島博基:性決定. 岩波講座 現代医学の基礎5, 生殖と発生(森嵩英, 山村研一, 編). 1999;pp 135-149, 岩波書店, 東京

• 11) Krob G, Braun A, Kuhnle U:True hermaphroditism:geographical distribution, clinical findings, chromosomes and gonadal histology. Eur J Pediatr 1994;153:2-10

• 12) van Niekerk WA, Retief AE:The gonads of human true hemaphrodites. Hum Genet 1981;58:117-122

• 13) Jones HW Jr, Scott WW:True hermaphroditism, Hermaphroditism, Genital Anomalies and Related Endocrine Disorders (Jones HW Jr, Scott WW, eds). 1971;pp290-317, Williams & Wilkins, Baltimore

• 14) Shima H, Okamoto K, et al:True hermaphroditism:Pre and postoperative evaluation of gonadal function and necessity of endoscopic examination for the search of cervix uteri at an early stage of diagnosis. Int Urol Nephrol 1991;23:495-502

• 15) Koopman P, Gubbay J, et al:Male development of chromosomally female mice transgenic for Sry. Nature 1991;351:117-121

• 16) Nakagomi Y, Seki S, et al:PCR detection of distal Yp sequences in an XX true hermaphrodite. Am J Med Genet 1991;41:112-114

• 17) McElreavey K, ViLain E, et al:A regulatory cascade hypothesis for mammalian sex determination:SRY repressed a negative regulator of male development. Proc Natl Acad Sci U S A 1993;90:3368-3372

• 18) 諸橋憲一郎, 野村政壽:生殖腺の性分化とAd4BP/SF-1 転写因子, 生物機能調節の要(藤井義明, 谷口維紹, ほか編). 1997;pp1033-1041, 共立出版, 東京

• 19) Harley VR, Jackson DI, et al:DNA binding activity of recombinant SRY from normal males and XY females. Science 1992; 255:453-456

• 20) Tommerup N, Schempp W, et al:Assignment of an autosomal sex reversal locus (SRA1) and campomelic dysplasia (CMPD1) to 17q24. 3-q25. 1. Nat Genet 1993;4:170-174

• 21) Wright E, Hargrave MR, et al:The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryo. Nat Genet 1995;9:15-20

• 22) Schneider S, Wildhadt G, et al:Exon shipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilm's tumor and severe genital malformations. Hum Genet 1993;91:559-604

• 23) Bardoni B, Zanaria E, et al:A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 1994;7:497-501

• 24) 中堀豊:Y染色体-構造・機能・進化. 蛋白質核酸酵素 1996(増刊号:"ヒト染色体"分子生物学から遺伝子医学へ);41:2306-2314

P.175 掲載の参考文献

• 1) Sohval AR:Hermaphroditism with "atypical" or "mixed" gonadal dysgenesis. Am J Med 1964;36:281-292
  pubmed

• 2) Zah W, Kalserone AE, et al:Mixed gonadal dysgenesis:A case report and review of the world literature. Acta Endocrinol (Suppl) 1975;197:3-39

• 3) Nonomura N, Nakamura M, et al:Mixed gonadal dysgenesis:case report and a review of 65 Japanese cases. Arch Androl 1991;26:15-19

• 4) Donahoe PK, Crawford JD, et al:Mixed gonadal dysgenesis, pathogenesis and management. J Pediatr Surg 1979;14:287-300

• 5) Monfort G:Transvesical approach to utricular cysts. J Pediatr Surg 1982;17:406-409

P.182 掲載の参考文献

• 1) Jacobs PA, Baikie AG, et al:Evidence for the existence of the human "super-famale". Lancet 1959;ii:423-425

• 2) Carr DH, Barr ML, et al:An XXXX sex chromosome complex in two mentally defective females. Can Med Assoc J 1961;84:131-137

• 3) Kesaree N, Wooley PV:A phenotypic female with 49 chromosomes, presumably XXXXX. J Pediatr 1963;63:1099-1103

• 4) Gowen JW:Meiosis as a genetic character in Drosophila malanogaster. J Exp Zool 1933;65:83-106

• 5) Matsunaga E:Down's syndrome and maternal inbreeding. Acta Genet Med Gemellol (Roma) 1966;15:224-230

• 6) Alfi OS, Chang R, et al:Evidence for genetic control of non-disjunction in man. Am J Hum Genet 1980;32:447-483

• 7) Yaegashi N, Senoo M, et al:Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older:collaborative study of 5484 cases. J Hum Genet 1998;43:85-90

• 8) Linden MG, Bmce MS, et al:47, XXX:What is the prognosis? Pediatrics 1988;82:619-630

• 9) Hassold T, Pettay D, et al:Analysis of non-disjunction in sex chromosome tetrasomy. Hum Genet 1990;85:648-650

• 10) Leal CA, Belmont JW, et al:Parental origin of the extra chromosomes in polysomy X. Hum Genet 1994;94:423-426

• 11) May KM, Jacobs PA, et al:The parental origin of the extra X chromosome in 47, XXX females. Am J Hum Genet 1990;46:745-761

• 12) Robinson WP, Binkert F, et al:Multiple origins of X chromosome tetrasomy. J Med Genet 1994;31:424-425

• 13) Kassai R, Hamada I, et al:Penta X syndrome:A case report with review of the literature. Am J Med Genet 1991;40:51-56

• 14) Deng H-X, Abe K, et al:Parental origin and mechanism of formation of polysomy X:an XXXXX case and four XXXXY cases determined with RFLPs. Hum Genet 1991;86:541-544

• 15) Boeck A, Gfatter R, et al:Pentasomy X and hyper IgE syndrome:co-existence of two distant genetic disorders. Eur J Pediatr 1999;158:723-726

• 16) 日暮眞, 飯島純夫:染色体異常の疫学. 医学のあゆみ 1982;121:600-606

• 17) Sergovich F, Uilenberg C, et al:The 49, XXXX chromosome constitution:Similarities to the 49, XXXXY condition. J Pediatr 1971;78:285-290

• 18) Linden MG, Bruce MS, et al:Sex chromosome tetrasomy and pentasomy. Pediatrics 1995;96:672-682

• 19) Polani PE:Abnormal sex chromosomes, behaviour and mental disorder. Developments in Psychiatric Research (Tanner J, ed). 1977;pp89-128, Hodder and Stoughton, London

• 20) Fryns JP, Kleczkowska A, et al:X-Chromosome polysomy in the female:personal experience and review of the literature. Clin Genet 1983;23:341-349

• 21) Ballesta F, Zapata M:Phenotype in triple-X patients. Clin Genet 1989;34:388-389

• 22) Spear GS, Porto M:47, XXX chromosome constitution, ovarian dysgenesis, and genito-urinary malformation. Am J Med Genet 1988;29:511-515

• 23) Villanueva AL, Rebar RW:Triple-X syndrome and premature ovarian failure. Obstet Gynecol 1983;62:70s-73s

• 24) Blackston RD, Grinzaid KS, et al:Reproduction in 48, XXXX women. Am J Med Genet 1994;52:379

• 25) Berg JM, Karlinsky H, et al:Twenty-six years later:a woman with tetra-X chromosomes. J Ment Def Res 1988;32:67-74

• 26) Bergemann E:Manifestation familiale du karyotype triploX. Communication preliminaire. J Genet Hum 1962;101370 371

• 27) Monheit A, Francke U, et al:The penta-X syndrome. J Med Genet 19680;17:392-396

• 28) Martin G, Carillo G, et al:On the parental origin of the X's in a prenatally diagnosed 49, XXXXX syndrome. Prenat Diagn 1993;13:763-766

• 29) Archidiacono N, Rocchi M, et al:X pentasomy:A case and review. Hum Genet 1979;52:69-77

• 30) Toussi T, Halal F, et al:Renal hypodysplasia and unilateral ovarian agenesis in the penta-X syndrome. Am J Med Genet 1980;6:153-162

• 31) Farge P, Dallaire L, et al:Oral and dental development in X chromosome aneuploidy. Clin Genet 1985;27:122-126

P.193 掲載の参考文献

• 1) Klinefelter HF, Reifenstein EC, Albright F:Syndrome characterized by gynecomastia, aspermatogenesis without a Leydigism and increased excretion of follicle-stimulating hormone. J Clin Endocrinol 1942;2:615-627

• 2) Jacobs PA, Strong JA:A case of human intersexuality having a possible XXY sex-determining mechanism. Nature 1959;83:302-303

• 3) 松尾宣武, 緒方 勤:Klinefelter症候群-臨床染色体診断法II(古庄敏行, 吉田迪弘, ほか編). 1996;pp490-492, 金原出版, 東京

• 4) Arps S, Koske-Westphal T, et al:Isochromosome Xq in Klinefelter syndrome:report of 7 new cases. Am J Med Genet 1996;64:580-582

• 5) Jacobs PA, Hassold TJ, et al:Klinefelter's syndrome:an analysis of the origin of the additional sex chromosome using molecular probes. Ann Hum Genet 1988;52:93-109

• 6) Lorda-Sanchez I, Binkert F, et al:Reduced recombination and paternal age effect in Klinefelter syndrome. Hum Genet 1992;89:524-530

• 7) Carothers AD, Filippi G:Klinefelter's syndrome in Sardinia and Scotland. Comparative studies of parental age and other aetiological factors in 47, XXY. Hum Genet 1988;81:71-75

• 8) Maeda T, Ohno M, et al:Cytogenetic survey of 14, 835 consecutive liveborn. Jpn J Hum Genet 1991;36:117-129

• 9) Yoshida A, Miura K, Shirai M:Cytogenetic survey of 1, 007 infertile males. Urol Int 1997:58:166-176

• 10) De Braekeleer M, Dao TN:Cytogenetic studies in male infertility:a review. Hum Reprod 1991;6:245-250

• 11) 浅香昭雄, 大木秀一:Klinefelter症候群. 別冊日本臨牀, 領域別症候群シリーズ, 内分泌症候群(上巻). 1993;No 1;799-801

• 12) Paulsen CA, Gordon DL, et al:Recent Klinefelter's syndrome and its variants:a hormonal and chromosomal study. Prog Honn Res 1968;24:321-363

• 13) Komatz Y, Kiriyama T, et al:Clinical observation in 100 cases of Klinefelter's syndrome. 日本不妊学会雑誌 1983;28:332-339

• 14) Okada H, Fujioka H, et al:Klinefelter's syndrome in the male infertility clinic. Hum Reprod 1999;14:946-952

• 15) Schibler D, Brook CG, et al:Growth and body proportions in 54 boys and men with Klinefelter's syndrome. Helv Peediatr Acta 1974;29:325-333

• 16) Salbenblatt JA, Bender BG, et al:Pituitary-gonadal function in Klinefelter syndrome before and during puberty. Pediatr Res 1985;19:82 86

• 17) Becker KL:Clinical and therapeutic experiences with Klinefelter's syndrome. Fertil Steril 1972;23:568-578

• 18) Yoshida A, Miura K, et al:Sexual function and clinical features of patients with Klinefelter's syndrome with the chief complaint or male infertility. Int J Androl 1997;20:8085
  pubmed

• 19) Kitamura M, Matsumiya K, et al:Ejaculated spermatozoa in patients with non-mosaic Klinefelter's syndrome. Int J Urol 2000;7:88-92

• 20) Gordon DL, Krmpotic E, et al:Pathologic testicular findings in Klinefelter's syndrome. 47, XXY vs 46, XY 47, XXY. Arch Intern Med 1972:130:726-729

• 21) Wang C, Baker HW, et al:Hormonal studies in Klinefelter's syndrome. Clin Endocrinol (Oxf) 1975;4:399-411

• 22) Anawalt BD, Bebb RA, et al:Serum inhibin B levels refiect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996;81:3341-3345

• 23) 篠原充, 原 慎, ほか:Klinefelter症候群における思春期の内分泌的および睾丸組織学的変化の検討. 日本泌尿器科学会雑誌 1989; 80:574-581

• 24) 福谷恵子:Klinefelter症候群における間脳-睾丸系の内分泌的研究. 日本泌尿器科学会雑誌 1971;67:671-674

• 25) Mikamo K, Aguercif M, et al:Chromatin-positive Klinefelter's syndrome. A quantitative analys is of spermatogonial deficiency at 3, 4, and 12 months of age. Fertil Steril 1968;19:731-739

• 26) 石田肇, 吉田英機:XXXXY症候群. 別冊日本臨牀, 領域別症候群シリーズ, 内分泌症候群(上巻). 1993;No 1:591-593

• 27) Regadera J, Codesal J, et al:Immunohistochemical and quantitative study of interstitial and intratubular Leydig cells in normal men, cryptorchidism, and Klinefelter's syndrome. J Pathol 1991;164:299-306

• 28) Skakkebaek NE, Philip J, Hammen R:Meiotic chromosomes in Klinefelter's syndrome. Nature 1969;221:1075-1076

• 29) Vidal F, Navarro J, et al:Synaptonemal complex studies in a mosaic 46, XY/47, XXY male. Hum Genet 1984;66:306-308

• 30) Cozzi J, Chevret E, et al:Achievement of meiosis in XXY germ cells:study of 543 sperm karyotypes from an XY/XXY mosaic patient. Hum Genet 1994;93:32-34

• 31) Chevret E, Rousseaux S, et al:Increased incidence of hyperhaploid 24, XY spermatozoa detected by three-colour FISH in a 46, XY/47, XXY male. Hum Genet 1996;97:171-175

• 32) Guttenbach M, Michelmann HW, et al:Segregation of sex chromosomes into sperm nuclei in a man with 47, XXY Klinefelter's karyotype:a FISH analysis. Hum Genet 1997;99:474-477

• 33) Foresta C, Galeazzi C, et al:High incidence of sperm sex chromosomes aneuploidies in two patients with Klinefelter's syndrome. J Clin Endocrinol Metab 1998;83:203-205

• 34) Rives N, Joly G, et al:Assessment of sex chromosome aneuploidy in sperm nuclei from 47, XXY and 46, XY/47, XXY males:comparison with fertile and infertile males with normal karyotype. Mol Hum Reprod 2000;6:107-112

• 35) Mroz K, Hassold TJ, Hunt PA:Meiotic aneuploidy in the XXY mouse:evidence that a compromised testicular environment increases the incidence of meiotic errors. Hum Reprod 1999;14:1151-1156

• 36) Foresta C, Galeazzi C, et al:Analysis of meiosis in intratesticular germ cells from subjects affected by classic Klinefelter's syndrome. J Clin Endocrinol Metab 1999;84:3807-3810

• 37) Mandoki MW, Sumner GS, et al:A review of Klinefelter's syndrome in children and adolescents. J Am Acad Child Adolesc Psychiatry 1991;30:167-172

• 38) Nielsen J, Sorensen AM, Sorensen K:Mental development of unselected children with sex chromosome abnormalities. Hum Genet 1981;59:324-332

• 39) Sasco AJ, Lowenfels AB, et al:Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53:538-549

• 40) Hultborn R, Hanson C, et al:Prevalence of Klinefelter's syndrome in male breast cancer patients. Anti-cancer Res 1997;17:4293-4297

• 41) Hasle H, Mellemgaard A, et al:Cancer incidence in men with Klinefelter syndrome. Br J Cancer 1995;71:416-420

• 42) Horowitz M, Wishart JM, et al:Osteoporosis and Klinefelter's syndrome. Clin Endocrinol (Oxf) 1992;36:113-118

• 43) Kubler A, Schulz G, et al:The influence of testosterone substitution on bone mineral density in patients with Klinefelter's syndrome. Exp Clin Endocrinol 1992;100:129-132

• 44) Bizzarro A, Valentini G, et al:Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J Clin Endocrinol Metab 1987;64:32-36

• 45) Huseh AH, Hsu TH, Federman DD:Endocrine features of Klinefelter's syndrome. Medicine 1978;57:447-461

• 46) 相楽衛男, 中園誠, ほか:顕性糖尿病を併発したKlinefelter症候群の2例と本邦報告例の観察. 糖尿病 1985;28:677-686

• 47) Linden MG, Bender BG, Robinson A:Sex chromosome tetrasomy and pentasomy. Pediatrics 1995;96:672-682

• 48) 奥山眞紀子:XXXXY症候群. 別冊日本臨牀, 領域別症候群シリーズ, 内分泌症候群(上巻). 1993;No 1:821-823

• 49) Nielsen J, Pelsen B, Sorensen K:Follow-up of 30 Klinefelter males treated with testosterone. Clin Genet 1988;33:262-269

• 50) Terzoli G, Lalatta E et al:Fertility in a 47, XXY patient:assessment of biological paternity by deoxyribonucleic acid fingerprinting. Fertil Steril 1992;58:821-822

• 51) Bourne H, Stem K, et al:Delivery of normal twins following the intracytoplasmic inlection of spermatozoa from a patient with 47, XXY Klinefelter's syndrome. Hum Reprod 1997;12:2447-2450

• 52) Reubinoff BE, Abeliovich D, et al:A birth in non-mosaic Klinefelter's syndrome after testicular fine needle aspiration, intracytoplasmic sperm injection and preimplantation genetic diagnosis. Hum Reprod 1998;13:1887-1892

• 53) Palermo GD, Schlegel PN, et al:Births after intracytoplasmic injection of sperm obtained by testicular extraction from men with nonmosaic Klinefelter's syndrome. N Engl J Med 1998;338:588-590

• 54) Nodar F, De Vincentiis S, et al:Birth of twin males with normal karyotype after intracytoplasmic sperm injection with use of testicular spermatozoa from a nonmosaic patient with Klinefelter's syndrome. Fertil Steril 1999;71:1149-1152

• 55) Ron-El R, Raziel A, et al:Birth of healthy male twins after intracytoplasmic sperm injection of frozen-thawed testicular spermatozoa from a patient with nonmosaic Klinefelter syndrome. Fertil Steril 2000:74:832-833

• 56) Ron-El R, Strassburger D, et al:A 47, XXY fetus conceived after ICSI of spermatozoa from a patient with non-mosaic Klinefelter's syndrome:case report. Hum Reprod 2000;15:1804-1806

• 57) Bielanska M, Tan SL, et al:Fluorescence in-situ hybridization of sex chromosomes in spermatozoa and spare preimplantation embryos of a Klinefelter 46, XY/47, XXY male. Hum Reprod 2000;15:440-444

P.201 掲載の参考文献

• 1) Jacobs PA, Brunton M, et al:Aggressive behavior, mental sub-normality and the XYY male. Nature 1965;208:1351-1352

• 2) Casey MD, Segall LJ, et al:Sex chromosome abnormalities in two state hospitals for patients in a security prisons. Nature 1966;219:351-354

• 3) Sandberg AA, Keepf GF, et al:An XYY human male. Lancet 1961;ii:488-489

• 4) Hook EB:Behavioral implications of the human XYY genotype. Science 1973;179:139-150

• 5) Asaka A:Frequencies of individuals with excess sex-chromosomes among mentally retarded, mentally ills, delinquent and criminal populations. Acta Crim Japon 1976;42:77-96

• 6) Pearson PL, Bobrow M, Vasa CG:Technique for identifying Y chromosomes inhuman interphase nuclei. Nature 1970;226:78-79

• 7) Jacobs PA, Melville M, et al:A cytogenetic survey of 11, 680 newborn infants. Ann Genet 1974;37:359-376

• 8) Friidrich V, Nielsen J:Chromosome studies in 5, 049 consecutive newborn children. Clin Genet 1973;4:333-334

• 9) Hamerton JL, Canning N, et al:A cytogenetic Survey of 14, 069 newborn infants. Clin Genet 1975;8:223-243

• 10) Lubs HA, Ruddle FH:Chromosomal abnormalities in the human population:Estimation of rates based on New Haven newborn study. Science 1970;169:495-497

• 11) Behrman RE, et al, ed:Nelson Textbook of Pediatrics, 16th ed. 2000, WB Saunders, Philadelphia

• 12) Nielsen J, Chistensen AL:Thirty-five with double Y chromosome. Psychol Med 1974;4:2837

• 13) Hamerton JL:Human cytogenetics II. 1971, Academic Press, New York, London

• 14) Noel B, Duport JP, et al:The XYY syndrome. Clin Genet 1974:5:387-394

• 15) Schiavi RC, Owen D, et al:Pituitary-gonadal function in XYY and XXY men identified in a population survey. Clin Endocrinol (Oxf) 1978;9:233-239

• 16) Caspersson T, Zech L, et al:Differential binding of alkylating fluorochromes in human chromosomes. Exp Cell Res 1970;60:315-319

• 17) Welch JP, Wellwood H:Fluorescent Y chromatin in newborn males. Am J Hum Genet 1974;26:247-251

• 18) Iijima K, Higurashi M, et al:Y chromatin and estrogen. Proc Jpn Acad 1980;56:131-134

• 19) Iijima K. Higurashi M, et al:Behavior of Y chromatin in the neonatal period. The Y chromosome (Sandberg AA, ed). 1985, Alan R Liss, New York

P.208 掲載の参考文献

• 1) Tiepolo L, Zuffardi O:Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum Genet 1976:34:119-124

• 2) Nagafuchi S, Namiki M, et al:A minute deletion of the Y chromosome in men with azoospermia. J Urol 1993:150:1155-1157

• 3) Ma K, Inglis JD, et al:A Y chromosome gene family with RNA-binding protein homology:candidates for the azoospermia factor AZF controlling human spermatogenesis. Cell 1993;75:1287-1295

• 4) Reijo R. Lee TY, et al:Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet 1995:10:383-393

• 5) Vogt PH, Edelmann A, et al:Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq 11. Hum Mol Genet 1996;5:933-943

• 6) Kent-First M, Muallem A, et al:Defining regions of the Y-chromosome responsible for male infertility and identification of a fourth AZF region (AZFd) by Y-chromosome microdeletion detection. Mol Reprod Dev 1999;53:27-41

• 7) Nakahori Y, Kuroki Y, et al:The Y chromosome region essential for spermatogenesis. Horm Res 1996:46 (Suppl):20-23

• 8) Simoni M, Kamischke A, Nieschlag E:Current status of the molecular diagnosis of Y chromosomal microdeletions in the work-up of male infertility. Hum Reprod 1998;13:1764-1768

• 9) Mulhall JP, Reijo R, et al:Azoospermic men with deletion of the DAZ gene cluster are capable of completing spermatogenesis:fertilization, normal embryonic development and pregnancy occur when retrieved testicular spermatozoa are used for intracytoplasmic sperm injection. Hum Reprod 1997;12:503-508

• 10) Silber SJ, Alagappan R, et al:Y chromosome deletions in azoospermic and severely oligozoospermic men undergoing intracytoplasmic sperm injection after testicular sperm extraction. Hum Reprod 1998;13:3332-3337

• 11) Page DC, Silber S, Brown LG:Men with infertility caused by AZFc deletion can produce sons by intracytoplasmic sperm injection, but arc likely to transmit the deletion and infertility. Hum Reprod 1999:14:1722-1726

P.214 掲載の参考文献

• 1) 瀧原博史, 内藤克輔:真性半陰陽. 最新内科学大系16, 性腺疾患(井村裕夫, 尾形悦郎, ほか編). 1993;pp254-259, 中山書店, 東京

• 2) Brup K:True hermaphroditism. Scand J Urol Nephrol 1996;30:73-74

• 3) 佐野克行, 寺島和光, ほか:真性半陰陽の4例. 泌尿器科紀要 1995;41:73-77

• 4) Conte FA, Grumbach MM:Abnormalities of sexual determination and differentiation. Smith's General Urology (Tanagho EA, McAninch JW, eds), 14th ed. 1995;pp696-727, Appleton & Lange, East Norwalk

• 5) Van Niekerk WA, Retief AE:The gonads of human true hermaphrodites. Hum Genet 1981;58:117-122

• 6) Griffin JE, Wilson JD:Disorder of sexual differentiation. Campbell's Urology (Walsh PC, Retik AB, et al, eds), 6th ed. 1992:pp1509-1542, WB Saunders, Philadelphia

• 7) Aleck KA, Argueso L, et al:True hermaphroditism with partial duplication of chromosome 22 and without SRY. Am J Med Genet 1999;85:2-4

• 8) Jimenez AL, Kofman-Alfaro S, et al:Partially deleted SRY gene confined to testicular tissue in a 46, XX true hermaphrodite without SRY in leukocytic DNA. Am J Med Genet 2000;93:417-420

• 9) 大島博幸, 酒井邦彦, ほか:真性半陰陽の細胞遺伝学的検索. 日本泌尿器科学会雑誌 1974;65:732-740

• 10) Jost A:Problems of fetal endocrinology:The gonadal and hypophyseal hormones. Recent Prog Horm Res 1953;8:379-418

• 11) Cohen-Haguenauer O, Picard JY, et al:Mapping of the gene for anti-mullerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet 1987;44:26

• 12) Houle A-M, Taketo T:True hermaphrodites:An experimental model in the mouse. J Urol 1992;148:672-676

• 13) 竹崎徹, 福井準之助, 芝 伸彦:真性半陰陽の2例-本邦報告100例の統計的考察-. 泌尿器科紀要 1976;22:657-668

• 14) 水谷修太郎, 園田孝夫, 松本圭史:真性半陰陽性腺組織によるステロイド生合成. 日本内分泌学会雑誌1971;47:491-492

• 15) German III JL, Beam AG, McGovem JH:Chromosomal studies of three hermaphroditism. Am J Med 1962;33:83-87

• 16) Ten Berge BS:True hermaphroditism with female chromatic pattern:Marriage between partners of the same sex. Gynecologia 1960;149:112-118

• 17) 万羽進, 安達武士, ほか:真性半陰陽患者の妊娠, 分娩例. 日本不妊学会雑誌 1971;16:110

• 18) Duckett JW:Transverse preputial island flap technique for repair of severe hypospadias. Urol Clin North Am 1980;7:423-430

• 19) 田苗綾子:性分化の障害. 新小児医学大系16-E, 小児内分泌学V(小林 登, ほか編). 1986;pp253-304, 中山書店, 東京

• 20) 柿澤至恕:半陰陽に対する治療方針. 小児外科 1989;21:277-286

• 21) Simpson JL, Photopulos G:The relationship of neoplasia to disorders of abnormal sexual differentiation. Birth Defects Orig Artic Ser 1976;12:15-50

• 22) Nihoul-Fekete C, Lortat-Jacob S, et al:Prevention of gonadal function in true hermaphroditism. J Pediatr Surg 1984;19:50-55

• 23) 杉本周路, 五十嵐匠, ほか:真性半陰陽の2例-小児腹腔鏡下手術の有用性について-. 日本泌尿器科学会雑誌 1998;89:971-974

P.221 掲載の参考文献

• 1) 藤枝憲二:ステロイド産生異常による性分化異常症の分子病態. Pharma Medica 2000;18:123-131

• 2) Pang SY, Wallace MA, et al:Worldwide experience and newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988;81:866-874

• 3) Yen SSC:Chronic anovulation caused by peripheral endocrine disorders. Reproductive Endocrinology, 3rd ed. 1991;pp613-617, WB Saunders, Philadelphia

• 4) 田苗綾子:副腎性器症候群. 治療 1998;80:988-989

• 5) 久保田俊郎, 麻生武志:副腎性器症候群. 産科と婦人科 1994;61:196-198

• 6) 鈴木裕代, 関原久彦:副腎性器症候群. 臨床医 1996;22:1316-1317

• 7) 谷風三郎, 上岡克彦, ほか:副腎性器症候群に対する外科的治療. 日本小児泌尿器科学会雑誌 1994;2:22-25

• 8) 石塚文平, 長島学:遅発月経の処理. 思春期学 1985;3:49-51

• 9) Perlmutter AD:Management of intersexuality. Campbell's Urology, Vol. 2. 1979, WB Saunders, Philadelphia

P.227 掲載の参考文献

• 1) Harada N, Ogawa H, et al:Biochemical and molecular genetic analyses on placental aromatase (P-450 AROM) deficiency. J Biol Chem 1992;267:4781-4785

• 2) Shozu M, Akafusa K, et al:A new case of female pseudohermaphroditism. J Clin Endocrinol Metab 1991:72:560-566

• 3) Harada N, Ogawa H, et al:Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. Am J Hum Genet 1992;51:666-672

• 4) Ito Y, Fisher CR, et al:Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci U S A 1993;90:11673-11677

• 5) Conte FA, Grumbach MM, et al:A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994;78:1287-1292

• 6) Morishima A, Grumbach MM, et al:Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. j Clin Endocrinol Metab 1995;80:3689-3698

• 7) Portrat-Doyen S, Forest MG, et al:Female pseudohermaphroditism (FPH) resulting from aromatase (P450arom) deficiency associated with a novel mutation (R457) in the CYP19 gene. Horm Res 1996;46 (suppl):14

• 8) Mullis PE, Yoshimura N, et al:Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene:Impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab 1997;82:1739-1745

• 9) Carani C, Qin K, et al:Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997;337:91-95

• 10) Ludwig M, Beck A, et al:Female pseudohermaphrodism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene. J Pediatr Endocrinol Metab 1998;11:657-664

• 11) Deladoey J, Fluck C, et al:Aromatase deficiency caused by a novel P450arom gene mutation:Impact of absent estrogen production on serum gonadotropin concentration in a boy. J Clin Endocrinol Metab 1999;84:4050-4054

• 12) Harada N, Honda S, et al:Histological lesions in aromatase-deficient mice. Molecular Steroidogenesis (Okamoto M, Ishimura Y, Nawata H, eds), Frontiers Science Series No 29. 1998;pp133-136, Univ Acad Press, Tokyo

• 13) Wilkens L:Masculinization of female fetus due to use of orally given progestins. JAMA 1960;172:1028-1032

• 14) Duck SC, Katayama KP:Danazol may cause female pseudohermaphrodism. Fertil Steril 1981;35:230-231

• 15) Bongiovanni AM, Di George AM, Grumbach MM:Masculinization of the female infant associated with estrogenic therapy alone during gestation:Four cases. J Clin Endocrinol Metab 1959;19:1104-1110

• 16) Forest MG, Orgiazzi J, et al:Approach to the mechanism of the androgen overproduction in a new case of Krukenberg tumor responsible for virilization during pregnancy. J Clin Endocrinol Metab 1978;47:428-434

• 17) Manganiello PD, Adams LV, et al:Virilization in pregnancy with spontaneous resolution postpartum:A case report and review of the English literature. Obstet Gynecol Surv 1995;50:404-410

• 18) Carpentier PJ, Potter EL:Nuclear sex and genital malformation in 48 cases of renal agenesis, with especial reference to nonspecific female pseudohermaphroditism. Am J Obstet Gynecol 1959;78:235-258

P.235 掲載の参考文献

• 1) 柳瀬敏彦, 高柳涼一:副腎. 新女性医学大系18, 思春期医学(武谷雄二, 青野敏博, ほか, 編). 2000:pp118-126, 中山書店, 東京

• 2) 柳瀬敏彦, 名和田新:性染色体と性の分化. 新女性医学大系28, 遺伝の基礎と臨床(武谷雄二, 青野敏博, ほか編). 2000;pp140-148, 中山書店, 東京

• 3) Pelletier J, Bruening W, et al:Germline mutations in the Wilms' tumor suppresor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991;67:437-447

• 4) Parker KL, Schimmer BP:Steroidogenic factor 1:a key determinant of endocrine development and function. Endocr Rev 1997;18:361-377

• 5) Achermann JC, Ito M, et al:A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet 1999;22:125-126

• 6) Biason-Lauber A, Schoenle EJ:Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insurnciency. Am J Hum Genet 2000;67:1563-1568

• 7) Wachtel SS:XX sex reversal in the human. Molecular Genetics of Sex Determination (Wachtel SS, ed). 1994:pp267-285, Academic Press, San Diego

• 8) Foster JW, Dominguez-Steglich MA, et al:Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994;372:525-530

• 9) Zanaria E, Muscatelli F, et al:An usual member of the nuclear hormone receptor superfamily responsible for X linked adrenal hypoplasia congenita. Nature 1994;372:635-641

• 10) Muscatelli F, Storm TM, et al:Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994;372:672-676

• 11) Bardoni B, Zanaria E, et al:A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal Nat Genet 199417:497-501

• 12) Swain A, Narvaez V, et al:Dax-1 antagonizes Sry action in mammalian sex determination. Nature 1998:391:761-767

• 13) Jameson JL:Inherited disorders of gonadotropin hormones. Mol Cell Endocrinol 1996;125:143-149

• 14) Rugarli El:Kallmann syndrome and the link between olfactory and reproductive development. Am J Hum Genet 1999;65:943 948

• 15) Latronico AC:Naturally occurring mutations of the luteinizing hormone receptor gene affecting reproduction. Semin Reprod Med 2000;18:17-20

• 16) Stocco DM, Clark BJ:Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 1996;17:221-244

• 17) Yanase T, Simpson ER, Waterman MR:17α-hydroxylase/17, 20-lyase deficiency:From clinical investigation to molecular definition. Endocr Rev 1991;12:91-108

• 18) 柳瀬敏彦, 大庭功一, 名和田新:副腎ステロイド合成酵素異常症の診断と治療の動向. ホルモンと臨床 1996;44:821-828

• 19) Mendonca BB, Inacio M, et al:Male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Diagnosis, psychological evaluation and management. Medicine (Battimore) 1996;75:64-76

• 20) Andersson S, Moghrabi N:Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 1997;62:143-147

P.243 掲載の参考文献

• 1) 高栄哲, 並木幹夫:生殖の生理. 新図説泌尿器科学講座1, 泌尿器科診断学. 1999;pp74-85, メジカルビュー社, 東京

• 2) Monis JM:The syndrome of testicular feminization in male pseudohermaphroditism. Am J Obstet Gynecol 1953;65:1192-1211

• 3) 松本圭史, 西沢恭子:アンドロゲン不応症. 代謝 1986;23:19-23

• 4) Reifenstein EG:Hereditary familial hypogonadism. Proc Am Fed Clin Res 1947;3:86

• 5) Lubahn DB, Brown TR, et al:Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci U S A 1989;86:5517-5521

• 6) 高柳涼一, 足立雅広, ほか:性ステロイド関連遺伝子と性分化異常:アンドロゲン受容体遺伝子. 小児内科 1998;30:1033-1037

• 7) 高柳涼一, 足立雅広, ほか:AR活性の細胞制御因子:ARの活性発現に必須のAF-1特異的共役因子の存在を示唆するアンドロゲン不応症. 日本内分泌学会雑誌 1999;75:366
  Medical*Online

P.251 掲載の参考文献

• 1) Stone D, Hechter O:Studies on ACTH action in perfused bovine adrenals:aspects of progesterone as an intermediary in corticosteroidogenesis. Arch Biochem Biophys 1954;51:457-468

• 2) Ferguson JJ:Protein synthesis and adrenocorticotropin. J Biol Chem 1963;238:2754-2759

• 3) Garren LD, Ney RL, Davis WW:Studies on the role of protein synthesis in the regulation of corticosterone production by ACTH in vivo. Proc Natl Acad Sci U S A 1965;53:1443-1450

• 4) Clark BJ, Wells J, et al:The purification, cloning, and expression of a novel LH-induced mitochondria protein in MA-10 mouse Leydig tumor cells:characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994;269:28314-28322

• 5) Lin D, Sugawara T, et al:Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995;267:1828-1831

• 6) Prader A, Gurtner HP:Das Syndrom des Pseudohermaphroditismus masculinus bei kongenitaler Nebennierenrinden-Hyperplasie ohne Androgenuberproduktion (adrenaler Pseudohermaphroditismus mas-culinus). Helv Paed Acta 1955;10:397-412

• 7) Lin D, Gitelman SE, et al:Normal genes for the cholesterol side chain cleavage enzyme, P450scc, incongenital lipoid adrenal hyperplasia. J Clin Invest 1991;88:1955-1962

• 8) Tee MK, Lin D, et al:T-A transversion 11 bp from a splice accepter site in the human gene for steroidogenic acute regulatory protein causes congenital lipoid adrenal hyperplasia. Hum Mol Genet 1995;4:2299-2305

• 9) Bose HS, Sugawara T, et al:The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl Med 1996;335:1870-1878

• 10) Nakae J, Tajima T, et al:Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet 1997;6:571-576

• 11) Fujieda K, Tajima T, et al:Spontaneous puberty in 46, XX subjects with congenital lipoid adrenal hyperplasia:Ovarian steroidogenesis is spared in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest 1997;99:1265-1271

• 12) Bose HS, Sugawara T, et al:The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl Med 1996;335:1870-1878

• 13) Caron KM, Soo SC, et al:Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci U S A 1997;94:11540-11545

• 14) Gwynne JT, Strauss JF III:The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 1982;3:299 329

• 15) Golos TG, Soto EA, et al:Human chorionic gonadotropin and 8-bromo-adenosine 3', 5'-monophosphate stimulate [125I] low density lipoprotein uptake and metabolism by luteinized human granulosa cells in culture. J Clin Endocrinol Metab 1985;61:633-638

• 16) Miller WL:Molecular biology of steroid hormone synthesis. Endocr Rev 1988;9:295-318

• 17) Strauss JF III, Miller WL:Molecular basis of ovarian steroid synthesis. Ovarian Endocrinology (Hiller SG, ed). 1991;pp25-72, Blackwell Scientific, New York

• 18) Hall PF:Cellular organization for steroidogenesis. Int Rev Cytol 1984;86:53-95

• 19) Privalle CT, Criello JF, Jefcoate CR:Regulation of intramitochondrial cholesterol transfer to side-chain cleavage cytochrome P450scc in rat adrenal gland. Proc Natl Acad Sci U S A 1983;80:702-706

• 20) Pon LA, Hartigan JA, Orme-Johnson NR:Acute ACTH regulation of adrenal corticosteroid biosynthesis:rapid accumulation of a phosphoprotein. J Biol Chem 1986;261:13309-13316

• 21) Pon LA, Epstein LF, Orme-Johnson NR:Acute cAMP stimulation in Leydig cells:rapid accumulation of a protein similar to that detected in adrenal cortex and corpus luteum. Endocr Res 1986;12:429-446

• 22) Epstein LF, Orme-Johnson NR:Regulation of steroid hormone biosynthesis:identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J Biol Chem 1991;266:19739-19745

• 23) King RK, Ronen-Fuhrmann T, et al:Steroid production after in vitro transcription, transiation, and mitochondrial processing of protein products of complementary deoxyribonucleic acid for steroidogenic acute regulatory protein. Endocrinology 1995:136:5165-5176

• 24) Stocco DM, Clark BJ:Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 1996;17:221-244

• 25) Sugawara T, Holt JA, et al:Human steroidogenic acute regulatory protein:Functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11. 2 and a pseudogene to chromosome 13. Proc Natl Acad Sci U S A 1995;92:4778-4782

• 26) Kiriakidou M, Sugawara T, et al:Expression of steroidogenic acute regulatory protein (StAR) in the human ovary. J Clin Endocrinol Metab 1996;81:4122-4128

• 27) Furukawa A, Miyatake A, ct al:Steroidogenic acute regulatory protein (StAR) transcripts constitutively expressed in the adult rat central nervous system:colocalization of StAR, cytochrome P-450SCC (CYPXIAI), and 3beta-hydroxysteroid dehydrogenase in the rat brain. J Nettrochem 1998;71:2231-2238

• 28) Moog-Lutz C, Tomasetto C, et al:MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas. Int J Cancer 1997;71:183-191

• 29) Watari H, Arakane F, et al:MLN64 contains a domain with homology to the steroidogenic acute regulatory protein(StAR) that stimulates steroidogenesis. Proc Natl Acad Sci U S A 1997;94:8462-8467

• 30) Ponting CP, Aravind L:START:a lipid-binding domain in StAR, HD-ZIP and signalling proteins. Trends Biochem Sci 1999;24:130-132

• 31) Arakane F, Sugawara T, et al:Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence:Implications for the mechanism of StAR action. Proc Natl Acad Sci U S A 1996;93:13731-13736

• 32) Sugawara T, Kiriakidou M, et al:Regulation of expression of the steroidogenic acute regulatory pro-tein (StAR) gene-A central role for steroidogenic factor 1. Steroids 1997;62:5-9

• 33) Christenson LK, Johnson PE et al:CCAAT/enhancer binding proteins regulate expression of the human steroidogenic acute regulatory protein (StAR) gene. J Biol Chem 1999:274:26591-26598

• 34) Sugawara T, Saito M, Fujimoto S:Sp1 and SF-1 interact and cooperate in the regulation of human steroidogenic acute regulatory protein gene expression. Endocrinology 2000;141:2895-2903

• 35) Zazopoulos E, Lalli E, et al:DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 1997;390:311-315

P.267 掲載の参考文献

• 1) The American Fertility Society:The American Fertility Society classifications of adnexal adhesions, distal tube occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Mullerian anomalies and intrauterine adhesions, Fertil Steril 1988;49:944-955

• 2) Mor N, Merlob P, Reisner SH:Types of hymen in the newborn infant. Eur J Ohstet Gynecol Reprod Biol 1986;22:225-228

• 3) 吉田勝彦, 牧野田知, 藤井亮太:性器閉鎖症. 臨床婦人科産科 1999;53:73-75

• 4) Makinoda S, Nishiya M, et al:Non-grafting method of vaginal construction for patients of vaginal agenesis without functioning uterus. Int Surg 1996;81:385-389

• 5) Hauser GA, Schreiner WE:Das Mayer-Rokitansky-Kuster Syndrom. Schweiz Med Wochenschr 1961;91:381-384

• 6) Griffin JE, Edwards C, et al:Congenital absence of the vagina. Ann Intern Med 1976;85:224-236

• 7) Alessandrescu D, Peltecu GC, et al:Neocolpopoiesis with split-thickness skin graft as a surgical treatment of vaginal agenesis:Retrospective review of 201 cases. Am J Obstet Gynecol 1996;175:131-138

• 8) Delga P, Potiron L:Sigmoid colpoplasty by laparoscopic and perineal surgery:a first case relative to Rokitansky-Kuster-Hauser syndrome. J Laparoendosc Adv Surg Tech A 1997;7:195-199

• 9) Bleggi-Torres LF, Werner B, Piazza MJ:Ultrastructural study of the neovagina following the utilization of human amniotic membrane for treatment of congenital absence of the vagina. Braz J Med Biol Res 1997;30:861-864

• 10) Soong YK, Chang FH, et al:Results of modified laparoscopically assisted neovaginoplasty in 18 patients with congenital absence of vagina. Hum Reprod 1996;11:200-203

• 11) Lapphn RE:Congenital absence of the vagina-results of conservative treatment. Eur J Obstet Gynecol Reprod Biol 1995;59:183-186

• 12) Jeffcoate RNA:Principles of Gynecology, 3rd ed. 1967, Appleton, Century Crofts, New York

P.279 掲載の参考文献

• 1) Goldman AS:Drugs and pregnancy. Pediatric Pharmacology (Yaffe SJ, ed). 1980, Grune & Stratton, New York

• 2) Hill RM:Drugs ingested by the pregnant woman. Clin Pharmacol Ther 1973;14:654
  pubmed

• 3) Wilson JG:Embryotoxicity of drugs in man. Handbook of Teratology (Wilson JG, Fraser FC, eds), Vol 1. 1977, Plenum Press, New York

• 4) Moore KL:The Developing Human, 3rd ed. 1982, WB Saunders, Philadelphia

• 5) Grumbach MM, Ducharme JR:The effects of androgens on fetal sexual development. Fertil Steril 1960;11:157-180

• 6) Emmens CW, Parkes AS:The effect of route of administration on the multiple activities of testosterone and methyltestosterone in different species. J Endocrinol 1939;1:323

• 7) Burns R:Hormones and the differentiation of sex. Survey of Biological Progress (Avery GS, et al, eds), Vol 1. 1949;pp 233-266, Academic Press, New York

• 8) Hayles AB, Nolan RB:Female pseudohermaphroditism:Report of case in an infant born of a mother receiving methyltestosterone during pregnancy. Proc Staff Meet, Mayo Clinic 1957;32:41

• 9) Grunwaldt E, Bates T:Nonadrenal female pseudohermaphrodism after administration of testosterone to mother during pregnancy. Pediatrics 1957;20:503
  pubmed

• 10) Gold AP, Michael AF Jr:Testosterone-induced female pseudohermaphrodism. J Pediatr 1958;52:279
  pubmed

• 11) Nellhaus G:Artificially-induced female pseudohermaphroditism. N Engl J Med 1958;258:935
  pubmed

• 12) Moncrieff A:Non-adrenal female pseudohermaphroditism associated with hormone administration in pregnancy. Lancet 1958;ii:267

• 13) Black JA, Bentley JFR:Effect on the foetus of androgens given during pregnancy. Lancet 1959;i:21

• 14) Wilkins L, Jones HW Jr, et al:Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation:Non-adrenal female pseudohermaphrodism. J Clin Endocrinol Metab 1958;18:559-585

• 15) Wilkins L:Masculinization of female fetus due to use of orally given progestins. JAMA 1960;172:1028-1032

• 16) Jacobson B:Hazards of norethindrone therapy during pregnancy. Am J Obstet Gynecol 1962;84:962-968

• 17) Burstein R, Wasserman HC:The effect of provera on the fetus. Obstet Gynecol 1964;23:931-934

• 18) 石塚直隆:合成黄体ホルモンによる女性新生児性器異常. 綜合臨牀 1963;12:2359-2367

• 19) Brunskill PJ:The effects of fetal exposure to danazol. Br J Obstet Gynaecol 1992;99:212-215

• 20) Voight W, Hsia SL:Further studies on testosterone 5α-reductase of human skin:structural features of steroid inhibitors. J Biol Chem 1973;248:4280-4285

• 21) Neumam F, von Berswordt-Wallrabe R, Elger W:Aspects of androgen-dependent events as studied by antiandrogens. Recent Prog Horni Res 1970;26:337-410

• 22) Prahalada S, Carroad E, et al:Embryotoxicity of a single dose of medroxyprogesterone acetate and maternal serum MPA concentrations in cynomolgus monkeys. Teratology 1985;32:421-432

• 23) Aaskog D:Maternal progestins as a possible cause of hypospadias. N Engl J Med 1979;300:75-78

• 24) Schardein JL:Hormones and hormonal antagonists. Chemically Induced Birth Defects. 1993;pp 271-339, Marcel Dekker, New York

• 25) Sweet RA, Schrott HG, et al:Study of the incidence of hypospadias in Rochester, Minnesota, 1940-1970, and a case control comparison of possible etiologic factors. Mayo Clin Proc 1974;49:52-58

• 26) Lorber CA, Cassidy SB, Engel E:Is there an embryo-fetal exogenous sex steroid exposure syndrome. Fertil Steril 1979;31:21-24

• 27) Toppari J, Skakkebaek NE:Sexual differentiation and environmental endocrine disrupters. Baiilieres Clin Endocrinol Metab 1998;12:143-156

• 28) Siegler AM, Wang CF, Friberg J:Fertility of the diethylstilbestrol-exposed offspring. Fertil Steril 1979;31:601-607

• 29) Singler MS, Hochman M:Incompetent cervix in a hormone-exposed offspring. Obstet Gynecol 1978:51:625-626

• 30) Kaufman RH, Adam E, et al:Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am J Obstet Gynecol 1980;137:299-308

• 31) Mangan CE, Borow L, et al:Pregnancy outcome in 98 women exposed to diethylstilbestrol in utero, their mothers, and unexposed siblings. Obstet Gynecol 1982;59:315-319

• 32) Herbst AL, Ulfelder H, Poskanzer DC:Adenocarcinoma of the vagina. N Engl J Med 1971;284:878-881

• 33) Herbst AL:Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer 1981;48:484-488

• 34) Melnick S, Cole P, et al:Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med 1987;316:514-516

• 35) Bongiovanni AM, Di George AM, Grumbach MM:Masculinization of the female infant associated with estrogenic therapy alone during gestation:four cases. J Clin Endocrinol Metab 1959;19:1104-1110

• 36) Gill WB, Schumacher GFB, et al:Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol 1979;122:36-39

• 37) Stillman RJ:In utero exposure to diethylstilbestrol:adverse effects on the reproductive tract and reproductive performance in male and female offspring. Am J Obstet Gynecol 1982;142:905-921

• 38) Wilcox AJ, Baird DD, Weinberg CR:Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med 1995;332:1411-1416

• 39) Kaplan NM:Male pseudohermaphrodism:report of a case, with observation on pathogenesis. N Engl J Med 1959;261:641-644

• 40) Newbold RR, McLachlan JA:Diethylstilbestrol associated defects in murine genital tract development. Estrogens in the Environment II:Influences on Development (McLachlan JA, ed). 1985;pp288-318, Elsevier, New York

• 41) Newbold RR, Bullock BC, McLachlan JA:Adenocarcinoma of the rete testis. Diethylstilbestrol-induced lesions of the mouse rete testis. Am J Pathol 1986;125:625-628

• 42) Sharpe RM, Skakkebaek NE:Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;341:1392-1395

• 43) Sharpe RM, Atanassova N, et al:Abnormalities in functional development of the Sertoli cells in rats treated neonatally with diethylstilbestrol:a possible role for estrogens in Sertoli cell development. Biol Reprod 1998;59:1084-1094

• 44) Majdic G, Sharpe RM, et al:Expression of cytochrome P450 17alpha-hydroxylase/C17-20 lyase inthe fetal rat testis is reduced by maternal exposure to exogenous estrogens. Endocrinol 1996;137:1063-1070

• 45) Sheehan DM, Young M:Diethylstilbestrol and estradiol binding to serum albumin and pregnancy plasma of rat and human. Endocrinology 1979;104:1442-1446

• 46) Imperato-McGinley J, Sanchez RS, et al:Comparison of the effects of the 5alfa-reductase inhibitor finasteride and antiandrogen flutamide on prostate and genital differentiation:dose-dependent studies. Endocrinology 1992;131:1149-1156

• 47) IPCS/OECD Steering Committee on Endocrine Disruptors. March, 1998

• 48) 環境ホルモン科学白書'99. 1999, 公害対策技術同友会, 東京

• 49) 西川淳一, 今川正良, 西原力:内分泌攪乱物質の核内ホルモン受容体に対する影響. 実験医学 2000;18:731-736

• 50) Gray LE Jr, Kelce WR:Latent effects of pesticides and toxic substances on sexual differenciation of rodents. Toxicol Ind Health 1996;12:515-531

• 51) Hankinson O:The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 1995;35:307-340

• 52) Miura J, Yamashita K, et al:Loss of teratogenic response to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 1997;2:645-654

• 53) Kolluri SK, Weiss C, et al:p27 (Kp1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 1999;13:1742-1753

• 54) Safe S, Wang F, et al:Ah receptor agonists as endocrine disruptors:antiestrogenic activity and mechanisms. Toxicol Lett 1998;102-103:343-347

• 55) Carlsen E, Giwercman A, et al:Evidence for decreasing quality of semen during past 50 years. Br Med J 1992;305:609-613

• 56) Auger J, Kunstmann JM, et al:Decline in semen quality among fertile men in Paris during the past 20 years. N Engl J Med 1995;332:281-285

• 57) Fisch H, Goluboff ET, et al:Semen analysis in 1283 men from the United States over a 25-year period:no decline in quality. Fertil Steril 1996;65:1009-1014

• 58) Paulsen CA, Berman NG, Wang C:Data from men in greater Seattle area reveals no downward trend in semen quality:further evidence that deterioration of semen quality is not geographically uniform. Fertil Steril 1996;65:1015-1020
  pubmed

• 59) Paulozzi LJ, Erickson JD, Jackson RJ:Hypospadias trends in two US surveillance system. Pediatrics 1997;100:831-834

• 60) Raman-Wilms L, Tseng AL, et al:Fetal genital effects of first-trimester sex hormone exposure:a meta-analysis. Obstet Gynecol 1995;85:141-149

• 61) Zober A, Hoffmann G, et al:Study of morbidity of personnel with potential exposure to vinclozolin. Occup Environ Med 1995;52:233-241

• 62) Gray LE Jr, Ostby JS, et al:Reproductive and thyroid effects of low-level polychlorinated biphenylexposure. Fundam Appl Toxicol 1993;20:288-294

• 63) Peterson RE, Theobald HM, Kimmel GL:Developmental and reproductive toxicity of dioxins and related compounds:cross-species comparisons. Crit Rev Toxico 1993;23:283-335

• 64) Gray LE Jr, Ostby JS:In utero TCDD alters reproductive morphology and function in female rat offspring. Toxicol Appl Pharmacol 1995;133:285-294

• 65) James WH:Secular trends in monitors of reproductive hazard. Hum Reprod 1997;12:417-421

P.291 掲載の参考文献

• 1) 山内俊雄:性転換手術は許されるのか. 性同一性障害と性のあり方. 1999, 明石書店, 東京

• 2) 山内俊雄, 東博彦, ほか:「性転換治療の臨床的研究」に関する審議経過と答申, 埼玉医科大学倫理委員会. 埼玉医科大学雑誌 1996;23:313-329

• 3) 日本精神神経学会:性同一性障害の診断と治療に関するガイドラインと提言. 精神神経誌 1997;99:533-540

• 4) 武重理英:精神分裂病の性同一性障害に関する臨床的研究. 東邦医学会雑誌 1995;41;569-578

• 5) 横山富士男, 庄野伸行, ほか:ヒステリー症状を伴ったGender Dysphoriaの1男子例. 東京精神医学会誌 1998;16:22-26

• 6) 阿部輝夫:性同一性障害関連疾患191例の臨床報告-統計分析と今後の問題点. 臨床精神医学 1999;28;373-381

• 7) 山内俊雄:性差とは何か;ジェンダーを通して男らしさ, 女らしさを考える. 埼玉医科大学雑誌 2000;27:70-77

• 8) 山内俊雄:性差とはなにか-性同一性障害をとおしてみた性差. 精神科治療学 2000;15:1051-1056

• 9) 山内俊雄, 加澤鉄士, ほか:性同一性障害の診断基準について-ICD-10とDSM-IV分類の比較を中心として. 2000, 第20回日本精神科診断学会発表

• 10) Van Goozen SH, Cohen-Kettenis PT, et al:Gender differences in behaviour:Activating effects of cross-sex hormones. Psychoneuroendocrinology 1995;20;343-363

• 11) 山内俊雄:性同一性障害とその成因. 脳の科学 1998;20:637-644

• 12) 山内俊雄:性同一性障害の診断. 性同一性障害の基礎と臨床(山内俊雄, 編著). 2001;pp38-52, 新興医学出版社, 東京

P.300 掲載の参考文献

• 1) 日本精神神経学会性同一性障害に関する特別委員会:性同一性障害に関する答申と提言. 精神神経学雑誌 1997;99:533-539

• 2) Meyer W, Bockting W, et al:The Standards of Care for Gender Identity Disorders-Sixth Version. The International Journal of Transgenderism (on line journal) 2001;5:1 (http://www. symposion. com/ijt/soc_2001/index. htm)

• 3) Money J:Ablatio penis:normal male infant sex-reassigned as a girl. Arch Sex Behav 1975;4:65-71

• 4) Diamond M:Pediatric management of ambiguous and traumatized genitalia. J Urol 1999;162:1021-1028

• 5) Diamond M, Sigmundson HK:Sex reassignment at birth. Long-term review and clinical implications. Arch Pediatr Adolesc Med 1997:151:298-304

• 6) 塚田 攻:性同一性障害の治療-摂食障害・性障害. 臨床精神医学講座第S4巻. 2000:pp497-504, 中山書店, 東京

• 7) 内島 豊:性同一性障害のホルモン療法. 性同一性障害の基礎と臨床. 2001;pp69-79, 新興医学出版社, 東京

• 8) Davidson BA:Concentric circle operation for massive gynecomastia to excise the redundant skin. Plast Reconstr Surg 1979;63:350 353

• 9) Hage JJ, Bouman FG, Bloem JJAM:Preconstruction of the pars pendulans urethrae for phalloplasty in female-to male transsexuals. Plast Reconstr Surg 1993;91:1303-1307

• 10) Hage JJ:Metaidoioplasty:an alternative phalloplasty technique in transsexuals. Plast Reconstr Surg 1996:97:161-167

• 11) Chang TS, Hwang WY:Forearm flap in one-stage reconstruction of the penis. Plast Reconstr Surg 1984;74:251 258

• 12) Glasson DW, Lovie MJ, Duncan GM:The ulnar forearm free flap in penile reconstruction. Aust N Z J Surg 1986:56:477-479

• 13) Upton J, Mutimer KL, et al:Penile reconstruction using the lateral arm flap. J R Coll Surg Edinb 1987:32:97-101

• 14) Harashina T, Inoue T, et al:Reconstruction of the penis with free deltoid flap. Br J Plast Surg 1990;43:217-222

• 15) Sadove R, Senzenger M, et al:One-stage total penile reconstruction with a free sensate osteocutaneous fibula flap. Plast Reconstr Surg 1993;92:1314-1324

• 16) Lenaghan R, Wilson N, et al:The role of rectosigmoid neocolporrhaphy. Surgery 1997;122:856-860

• 17) Small MP:Penile and scrotal inversion vaginoplasty for male to female transsexuals. Urology 1987;29:593-597

• 18) Eldh J:Construction of a neovagina with preservation of the glans penis as a clitoris in male transsexuals. Plast Reconstr Surg 1993;91:895 903

P.309 掲載の参考文献

• 1) Grumbach MM, Conte FA:Disorders of sex differentiation. Williams Textbook of Endocrinology (Wilson JD, Foster W, et al, eds), 9th ed. 1998;pp 1303-1425, WB Saunders, Philadelphia

• 2) 日比逸郎:社会的性の選択とその変更に必要な法的手続きと心理的カウセンリング. 小児科MOOK 59, 性の分化と成熟の異常(日比逸郎, 編). 1990;pp148-154, 金原出版, 東京

• 3) Fujieda K, Matsuura N:Growth and maturation in the male genitalia from birth to adolescence. II. Changes of penile size. Acta Paediatr Jpn 1987;29:220-223

• 4) Migeon CJ, Wisnlewski AB:Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Growth, development, and therapeutic considerations. Endocrinol Metab Clin North Am 2001;30:193-206

• 5) 諏訪誠三, 五十嵐良雄, ほか:新生児マススクリーニングで発見された先天性副腎過形成症(21-水酸化酵素欠損症)の治療指針 (1989). 日本小児科学会雑誌 1989;93:1904-1906

• 6) 楠田聡, 立花克彦, ほか:新生児マススクリーニングで発見された先天性副腎過形成症(21-水酸化酵素欠損症の治療指針(1999年改訂). 日本小児科学会雑誌 1999;103:698-701

• 7) Rivkees SA, Crawford JD:Dexamethasone treatment of virilizing congenital adrenal hyperplasia:The ability to achieve normal growth. Pediatrics 2000;106:767-773

• 8) 立花克彦, 諏訪誠三:酢酸フルドロコルチゾンの新生児・乳児期における至適投与量の再検討. 日本小児科学会雑誌 1998;102:880-884

• 9) Burstein S, Grumbach MM, Kaplan SL:Early determination of androgen-responsiveness is important in the management of microphallus. Lancet 1979;ii:983-986

• 10) Husmann DA, Cain MP:Eventual phallic size is dependent on the timing of androgen administration. J Urol 1994;152:734-739

• 11) Aaronson IA:Micropenis:medical and surgical implications. J Urol 1994;152:4-14

• 12) McMahon DR, Kramer SA, Husmann DA:Micropenis:does early treatment with testosterone do more harm than good? J Urol 1995;154:825-829

• 13) Sutherland RS, Kogan BA, et al:The effect of pre-pubertal androgen exposure on adult penile length. J Urol 1996;156 (Pt2):783-787

• 14) Choi SK, Han SW, et al:Transdemmal dihydrotestosterone therapy and its effect on patients with microphallus. J Urol 1993;150 (Pt2):657-660

• 15) 島博基, 生駒文彦:性分化異常. 小児泌尿器学全書(川村孟, 小柳知彦, 編). 1998;pp317-353, 金原出版, 東京

• 16) Wilson JD, Griffin JE:The use and misuse of androgens. Metabolism 1980;29:1278-1295

• 17) Snyder PJ, Lawrence DA:Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab 1980;51:1335-1339

• 18) 前坂機江:原発性性腺機能低下症. 専門医による小児内分泌疾患の治療. 1997;pp57-78, 診断と治療社, 東京

• 19) Neely EK:Estrogen for feminization:a review. Turner syndrome in a Life Span Perspective:Research and Clinical Aspects (Albertson-Wikland K, Ranke MB, eds). 1995;pp219-226, Elsevier Science Publications BV, Amsterdam

• 20) Saenger P, Wikland KA, et al:Recommendation for the diagnosis and management of Turner syndrome. J Clin Endecrinol Metab 2001;86:3061-3069

• 21) 奥野晃正:ターナー症候群の治療. 性ステロイドホルモン, 小児期, ターナー症候群(岡田義昭, 監). 1995;pp282-289, メディカルレビュー社, 大阪

• 22) Rosenfeld RG, Attie KM, et al:Growth hormone therapy of Turner's syndrome. J Pediatr 1998;132:319-324

• 23) Takano K, Shizume K, et al:Long-term effects of growth hormone treatment on height in Turner syndrome:results of a 6-year multi-centre study in Japan. Horm Res 1995;43:141-143

• 24) Carel J, Mathivon L, et al:Near normalization of final height with adapted doses of growth hormone in Turner's syndrome. J Clin Endocrinol Metab 1998;83:1462-1466

• 25) Tanaka T, Takano K, et al:Final height in Turner syndrome after growth hormone treatment;Japanese study. Optimizing Health Care fort Turner Patients in the 21st Century (Saenger R Pasquino AM, eds). 2000;pp223-228, Elsevier Science Publications BV, Amsterdam

• 26) Igarashi Y, Ogawa E, et al:Treatment of Turner syndrome with transdermal estradiol (Estraderm(R)). Basic and Clinical Approach to Turner Syndrome (Hibi I, Takano K, eds). 1993:pp197-201, Elsevier Science Publications BV, Amsterdam

• 27) Jospe N, Orlowski CC, Furlanetto RW:Comparison of transdermal and oral oestrogen therapy in girls with Turner's syndrome. J Pediatr Eiidocrinol Metab 1995;8:111-116

P.318 掲載の参考文献

• 1) Lin D, Sugawara T, et al:Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995;267:1828
  pubmed

• 2) 柳瀬敏彦, 大庭功一, 名和田新:日本における副腎疾患の現状とその対策 副腎ステロイド合成酵素異常症の診断と治療の動向(解説/特集). ホルモンと臨床 1996;44:821-828

• 3) Rheaume E, Lachance Y, et al:Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. Mol Endocrinol 1991;5:1147-1157

• 4) Eldar-Geva T, Hurwitz A, et al:Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia. N Engl J Med 1990;323:855-863

• 5) Yanase T, Simpson ER, Waterman MR:17 alpha-hydroxylase/17, 20-lyase deficiensy:from clinical investigation to molecular definition. Endocr Rev 1991;12:91-108

• 6) 名和田新, 高柳涼一:副腎性器症候群・成人多毛症の診断と治療. 図説病態内科学13(高久史麿, 監;紫芝良昌, 猿田亨男, 編). 1995;pp74-79, メジカルビュー社, 東京

• 7) Siegel SE Lanes R, Lee PA:ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism. N Engl J Med 1990;323:849-854

• 8) 高柳涼一, 岡部泰二郎, ほか:副腎皮質機能低下症のホルモン補充療法-副腎アンドロゲンDHEAの生理作用と補充療法の可能性. ホルモンと臨床 1995;43:591-600

• 9) 清水直容, 堀内敏行, 木野内喬:男性化副腎腫瘍. ホルモンと臨床 1984:32(秋季増刊号):156-163

• 10) 名和田新:副腎疾患の成因と治療. 成人多毛症. 日本内科学会雑誌 1992; 81:501-505

• 11) 名和田新, 土師正文, 高柳涼一:内分泌疾患と代謝異常:男性化症候群. 日本臨牀 1991;49(増刊号:最新薬物療法manual下巻):815-816

• 12) 高柳涼一, 名和田新:女性性機能. 男性化症候群. 日本臨牀 1993;別冊 内分泌症候群 上巻:738-741

P.329 掲載の参考文献

• 1) 佐藤博:機能性子宮をもつ腟欠損症に対する新しい治療法. 北海道医学雑誌 1987:68:476-484

• 2) Frank RT:The formation of an artificial vagina without operation. Am J Obstet Gynecol 1938;35:1053 '

• 3) Wharton KR:A simplified method of constructing a vagina. Ann Surg 1938;107:842-847

• 4) Vecchietti G:Le neo-vagin dans le syndrome de Rokitansky-Kuster-Hauser. Rev Med Suisse Romande 1979;99:593-601

• 5) Williams EA:Congenital absence of the vagnina:A simple operation for its relief. J Obstet Gynaecol Br Commonw 1964;71:511
  pubmed

• 6) McIndoe AH, Banister JB:An operation for the cure of congenital absence of the vagina. J Obstet Gynaecol Br Commonw 1938;45:490

• 7) Ruge E:Ersatz der Vagina durch die Flexur mittels Laparotomie. Deut Med Wschr 1914;40:120-122

• 8) Fedele L, Busacca M, et al:Laparoscopic creation of a neovagina in Mayer-Rokitansky-Kuster-Hauser syndrome by modification of Vecchietti's operation. Am J Obstet Gynecol 1994;171:268-269

• 9) Langebrekke A, Istre O, et al:Laparoscopic assisted colpoiesis according to Davydov. Acta Obstet Gynecol Scand 1998;77:1027-1028

• 10) Ichinoe K:Vaginal construction for the patients of vaginal agenesis. Functional Preservation of Gynecologic Reproductive Organs by Operative and Non-operative Procedure (Ichinoe K, ed). 1986;pp39-55, Hokkaido University Medical Library, Sapporo

• 11) Troche V, Hemandez E:Neoplasia arising in dysgenetic gonads. Obstet Gynecol Surv 1986;41:74-79

• 12) 西田正人:子宮奇形. 図説産婦人科 VIEW20 1996:pp26-47, メジカルビュー社, 東京

• 13) 古谷健一, 永田一郎:人工真皮を用いた新しい造腟術-Mayer-Rokitansky-Kuster-Hauser症候群における各種造腟術の比較と新しい試み. 図説産婦人科VIEW34, 子宮・卵管・腟の形成手術-妊孕能温存とQOLの向上をめざして(河上征治, 矢嶋 聰, 編). 1998;pp 112-121, メジカルビュー社, 東京

• 14) Seki T, Fujimoto S, et al:Long arm deletion of the X chromosome, 46, X, del(X) (q21), associated with gonadoblastoma. Jpn J Hum Genet 1981;26:307-312

P.344 掲載の参考文献

• 1) Tennenbaum SY:Problems in pediatric gynecology:The role of the pediatric urologist. Dial Pediatr Urol 1993;16:1-8

• 2) 野々村克也, 小山敏樹, ほか:性染色体モザイク症の臨床的検討-内分泌動態と性腺のGlutathion S-transferaseの組織科学. 日本泌尿器科学会雑誌 1990;81:359-366

• 3) Scully RE:Neoplasia associated with anomalous sexual development and abnormal sex chromosomes. Pediatr Adolesc Endocr 1981;8:203-217

• 4) Telvi L, Lebbar A, et al:45, X/46, XY mosaicism:Report of 27 cases. Pediatrics 1999;104:304-308

• 5) Morita K, Nonomura K, et al:Experience of laparoscopic exploration and gonadectomy in intersex children. Diagnostic & Therapeutic Endoscopy 1998;4:127-133

• 6) Colapinto J:The true story of John/Joan. Rolling Stone 1997;775:54-73, 92-97

• 7) 野々村克也, 山口 脩:Urologic SurgeryシリーズNo 5, 小児泌尿器科手術. 2000, メジカルビュー社, 東京

• 8) Gross RE, Randolph J, et al:Clitorectomy for sexual abnormalities:Indication and technique. Surgery 1966;59:300-308

• 9) Lattimer JK:Relocation and recession of the enlarged clitoris with preservation of the glans:An alternative to amputation. J Urol 1961;86:113-116

• 10) Spence HM, Allen TD:Genital reconstruction in the female with the adrenogenital syndrome. Br J Urol 1973;45:126-130

• 11) Kumar H, Kiefer JH, et al:Clitoroplasty:Experience during a 19-year period. J Urol 1974;111:81-84

• 12) Hendren WH, Donahoe PK:Correction of congenital abnormalities of the vagina and perineum. J Pediatr Surg 1980;15:751-763

• 13) Gearhart JP:Editorial comment in "Long-term follow-up of female patients with congenital adrenal hyperplasia from 21-hydroxylase deficiency, with special emphasis on the results of vaginoplasty. BJU Int 2000;86:258-259

• 14) Fortunoff S, Lattimer JK, et al:Vaginoplasty technique for female pseudohermaphrodites. Surg Gynecol Obstet 1964;118:545-548

• 15) Bailez MM, Gearhart JP, et al:Vaginal reconstruction after initial construction of the external genitalia in girls with salt-wasting adrenal hyperplasia. J Urol 1992;148:680-682

• 16) Nonomura K, Kakizaki H, et al:Vaginoplasty with the bilateral labioscrotal flap:A new flap vaginoplasty. Reconstructive Surgery of the Lower Urinary Tract in Children (Thuroff JW, Hohenfellner M, eds). 1995;pp236-242, ISIS Medical Media, Oxford

• 17) Nonomura K, ]Faniguchi A:Experience of vaginoplasty with the bilateral labio-scrotal flap in intersex children. BJU Int 2000;86 (Suppl 3):25-26

• 18) Donahoe PK, Hendren WH:Perineal reconstruction in ambiguous genitalia infants raised as females. Ann Surg 1984:200:363-371

• 19) 谷風三郎:女性外陰・形成術. 小児泌尿器科手術書(川村 猛, 小柳知彦, ほか編). 1999;pp233-241, 金原出版, 東京

• 20) Hendren WH:Repair of cloacal anomalies:Current techniques. J Pediatr Surg 1986;21:1159-1176

• 21) 野々村克也, 山下哲史, ほか:尿路・性器再建におけるPosterior-sagittal Incision (PenaのIncision)の経験. 日本小児泌尿器科学会雑誌 1995;3:32-40

• 22) Frank RT:The formation of an artificial vagina without operation. Am J Obstet Gynecol 1938;35:1053-1055

• 23) 一戸喜兵衛, 関敏雄:機能性子宮をもつ腟欠損症の治療. 日本産科婦人科学会雑誌 1985;37:307-312

• 24) McIndoe A:The treatment of congenital absence and obliterative conditions of the vagina. Br J Plast Surg 1950;2:254-267

• 25) Woods JE, Alter G, at al:Experience with vaginal reconstruction utilizing the modified Singapore flap. Plast Reconstr Surg 1992;90:270-274

• 26) Belloli G, Campobasso P, et al:Labial skin-flap vaginoplasty using tissue expanders. Pediatr Surg Int 1997;12:168-171

• 27) Burger RA, Riedmiller H, et al:Ileocecal vaginal construction. Am J Obstet Gynecol 1989;161:162-167

• 28) Tamaya T, Fujimoto J:Comparison between transabdominal-vulvar and transvulvar approaches for peritoneal vaginoplasty in patients with congenital absence of the vagina. Eur J Obstet Gynecol Reprod Biol 1997;72:79-81

• 29) Tillem SM, Stock JA, et al:Vaginal construction in children. J Urol 1998;160:186-190

P.354 掲載の参考文献

• 1) ターナー女性を支える医師の会:ターナー女性-本人と家族のために. 1999, メディカルレビユー社, 東京

• 2) 奥野晃正:絵で見るターナー症候群. 1999, メディック, 東京

• 3) Fujita K:Social problems in Turner syndrome. Clin Pediatr Endocrinol 1997;6(Suppl 9):7-12

• 4) 藤田敬之助:ターナー症候群のQOLとその向上にむけて. 産科と婦人科 1997;64:637-642

• 5) Lee PA, Witchel SF:Changes in genital surgery among 46XX 21-hydroxylase deficiency patients over the past 5 decades (Abstract). Pediatr Res 2001;49:46A

• 6) Mulaikal RM, Migeon CJ, Rock JA:Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987:316:178-182

• 7) Jaaskelainen JES:Sexual function and fertility in adult males and females with congenital adrenal hyperplasia (Abstract). Pediatr Res 2001:49:6A

• 8) 藤田敬之助:性分化のOverview精神的心理的ケア 小児. 臨床婦人科産科 1999:53:2831

• 9) 小田切明徳, 橋本秀雄:インターセクシュアル(半陰陽者)の叫び. 1997, かもがわ出版, 京都

• 10) 松崎有子:あいだの性. いのちジャーナル 1998;6:18-25

• 11) Wisniewski AB, Migeon CJ, et al:Partial androgen insensitivity syndrome and partial gonadal dysgenesis:Long-term medical, surgical and psychosexual outcome of patients reared male or female (Abstract). Pediatr Res 2001;49:51A
  pubmed

P.360 掲載の参考文献

• 1) Carrascosa A, Gussinye M, et al:Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J Bone Miner Res 2000;15:2005-2010

• 2) 玉置(橋本)知子, 妹尾純子, 澤井英明:6遺伝相談. New Epoch産科外来診療(岡井 崇, 編). 1999;pp41-44, 医学書院, 東京

• 3) 岡田義昭:ターナー症候群の精神社会的様相. ターナー症候群(岡田義昭, 監). 1995;pp 170-195, メディカルレビュー社, 東京

• 4) 藤田敬之助:Turner症候群. 周産期遺伝相談(神崎秀陽, 玉置知子, 編). 2000;pp 136-138, 医学書院, 東京

• 5) Elsheikh M, Conway GS, Wass JAH:Medical problems in adult women with Turner's syndrome. Ann Med 1999;31:99-105

• 6) Cunniff C, Hassed SJ, et al:Health care utilization and perceptions of health among adolescents and adults with Turner syndrome. Clin Genet 1995;48:17-22

• 7) Kleczkowska A, Kubien E, et al:Turner syndrome:II. Associated anomalies, mental performance and psychological problems in 218 patients diagnosed in Leuven in the period 1965-1989. Genet Couns 1990;1:241-249

• 8) Skuse D:Annotation the psychological consequences of being small. J Child Psychol Psychiatry 1987;28:641-650

• 9) 石川雅世, 日高恵以子, ほか:習慣流産とX染色体モノソミー低頻度モザイク-頬粘膜細胞と末梢血リンパ球細胞を用いた間期核FISH法による解析. 臨床病理 2000;48:955-959

• 10) ANDROGEN INSENSITIVITY SYNDROME; AIS. Online Mendelian Inheritance in Man, http://www3. ncbi. nlm. nih. gov/htbin-post/Omim/dispmim?300068

• 11) SEX-DETERMINING REGION Y;SRY. Online Mendelian Inheritance in Man, http://www3. ncbi. nlm. nih. gov/htbin-post/Omim/dispmim?480000